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 Pregnancy induces marked changes in the maternal organism, many of them related to 
the cardiovascular and renal functions. The hemodynamic adaptation to pregnancy results in 
the institution of a high flow and low resistance circulation. This so-called ‘hyperdynamic 
circulation’ is characterized by a rise in cardiac output (CO) ‒ mainly by a rise in stroke 
volume (SV) ‒ and a fall in total systemic vascular resistance without concomitant rise in 
oxidative metabolism [1]. The observed changes appear to be secondary to an initial, preg-
nancy-specific, systemic vascular relaxation, which not only leads to the development of this 
hyperdynamic circulation, but also enhances sodium and water retention so as to raise plasma 
volume [2-5]. Although the functional meaning of these changes is still obscure, their import-
ance for a normal course of pregnancy is emphasized by the epidemiological observation that 
hypertensive complications of pregnancy such as preeclampsia, the HELLP syndrome and 
placental insufficiency, are often preceded by the defective development of this adaptive 
response to pregnancy [6-7]. 
 Almost 6-8% of all pregnancies are complicated by hypertensive disorders [8] and these 
complications in turn, are major contributors to maternal mortality in developing countries 
[9]. Unfortunately, management of hypertensive disorders in pregnancy is still limited to 
symptomatic treatment and, in case of inadequate response, to (often preterm) termination of 
pregnancy. 
 Today, there is compelling evidence for all discernable hemodynamic changes in 
pregnancy to be triggered by an initial systemic vasorelaxation [2-5]. Unraveling the 
underlying mechanism of this phenomenon is expected to improve our insight in the patho-
physiology of maladaptation to pregnancy as frequently seen in the subclinical phase of 
hypertensive disorders in pregnancy [10]. Systemic vasodilatation along with its induced 
hemodynamic compensations is already detectable in the 5th week of human pregnancy [2] 
and is also observed at a correspondingly early stage of pregnancy in other mammals such as 
sheep [11] and rat [12]. The latter animal is a suitable research model for the study of 
pregnancy-related hemodynamic changes as these resemble closely those observed in human 
pregnancy [12].  
Vasodilatation can be induced by neural, hormonal and neurohormonal stimuli or 
mechanically, by a rise in blood flow. These stimuli in turn, may employ different signal-
transduction pathways to trigger the vascular response. So far, it seems unlikely that the fall in 
systemic vascular tone in early pregnancy is induced by some unique pregnancy-specific 
factor or change in signal-transduction pathway. In the search for such an overall mechanism, 
several candidate contributors have been identified without a single one being really 
dominant. These contributors will be discussed one by one in the following paragraphs. 
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1.1 STEROIDS AND RELAXIN 
 
17β-estradiol 
The vasodilator properties of 17β-estradiol have been studied extensively in various 
different mammals. In these studies administration of 17β-estradiol always induced regional 
vasodilatation in the uterus and other reproductive tissues [11,13-16], accompanied by syste-
mic vasodilatation in ewes [15,17], guinea pigs [18] and male transsexuals [19]. Although 
chronic i.v. administration of 17β-estradiol in sheep raised CO and SV without concomitant 
change in mean arterial pressure (MAP) [11,13], the initial marked rise in uterine blood flow 
diminishes gradually in spite of ongoing infusion [11]. Part of the vasodilator effect of 17β-
estradiol results from stimulation of endothelial nitric oxide synthase [NOS] [20-24]. This 
vasodilator response is dependent on shear stress and therefore, is considered ‘flow-induced 
vasorelaxation’ [25]. After binding to specific ‘non-genomic’ membrane-bound estrogen 
receptors, 17β-estradiol has also been found to trigger a NO-independent vasodilator response 
[26-27], probably mediated by activation of large conductance calcium-dependent potassium 
channels [28]. 
 
Progesterone 
Administration of progesterone elicits acute endothelium-independent vasodilatation, 
probably through the cyclic AMP pathway, in 1st and 2nd order human umbilical arteries and 
veins [29] and in human omental arteries [26]. In rat mesenteric arteries, progesterone also 
induces both endothelium-dependent and -independent relaxation [30]. Chronic 
administration of progesterone to rat results in a state of ‘pseudopregnancy’ [31], resembling 
the hormonal changes of pregnancy. During pseudopregnancy in rat, the cardiac output is 
raised and the peripheral vascular resistance reduced [32] resembling the hemodynamic 
changes of normal rat pregnancy [12]. The underlying mechanism of this progesterone-related 
effect is unclear. However, the similar circulatory changes in pseudopregnancy as in normal 
pregnancy support the view that the trophoblast plays a negligible role in the induction of the 
initial vasorelaxation of pregnancy. 
 
Relaxin 
Relaxin is a hormone of the insulin family of peptides produced and ‒ during pregnancy 
‒ secreted by the corpus luteum in mice, rat and human [33]. It regulates growth and 
remodeling of reproductive tissues during advanced pregnancy but also during decidualization 
[34]. It is involved in the pregnancy-induced renal vasodilatation as suggested by the rapid 
onset of this effect after administration [35] and by the disappearance of this effect after the 
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administration of neutralizing antibodies or after ovariectomy in midpregnant rat [36]. How-
ever, the midpregnancy fall in blood pressure is neither inhibited in ovariectomized, steroid-
supplemented rats [37] nor attenuated in response to relaxin-neutralizing antibodies [36]. The 
administration of the latter antibodies to pregnant rat reduces cardiac output to the 
nonpregnant level without altering heart rate, mean arterial pressure and structure of the 
arteries [38]. Although, the exact mechanism of the vasodilator properties of relaxin is still 
unclear, it partly seems to induce vasodilatation by converting endothelin in inactive 
fragments [39] and by activation of so called ETB receptors that have been proposed to 
stimulate the release of NO by the endothelium [40,41]. 
 
   
1.2 VASODILATOR PEPTIDES: CALCITONIN GENE-RELATED PEPTIDE, 
ADRENOMEDULLIN, NITRIC OXIDE AND RELATED AGENTS  
 
Calcitonin gene-related peptide  
Calcitonin Gene-Related Peptide (CGRP) is a 37-amino-acid vasoactive neuropeptide 
that is mainly expressed in the dorsal-root ganglia. It is the most potent endogenous 
vasodilator and is released from the sensory-motor nerves, which are distributed throughout 
the cardiovascular system [42]. The classical mechanism leading to release of CGRP is by 
stimulation of the sensory-motor nerves by capsaicin, a vanilloid pungent [43]. Substances 
considered to act via the same vanilloid receptors on sensory-motor nerves include kinins and 
prostaglandins [44,45] and NO [46]. Other substances, such as histamine, neuropeptide Y and 
vasoactive intestinal polypeptide modulate CGRP release through their own specific receptors 
located on sensory nerves [42]. Stimulation of α2-adrenoreceptors, located presynaptically on 
sensory-motor nerves was demonstrated to inhibit CGRP release [47]. Both in women taking 
contraceptive pills [48] and postmenopausal women receiving hormonal replacement therapy 
[49] circulating levels of CGRP are increased, suggesting a modulating effect of steroid 
hormones on CGRP release. Indeed, in rat, pregnancy and steroids induce a rise in circulating 
CGRP concentration [50] probably due stimulation of the sensory-motor nerves by nerve 
growth factor [51]. In women, increasing CGRP levels are demonstrated from the third month 
of gestation, with a sharp decline to normal on the fifth day after delivery [52,53]. The 
administration of steroids enhances the vasodilator properties of CGRP [54,55]. In advanced 
pregnancy the sensitivity to CGRP is enhanced in both the vasculature [55,56] and the 
myometrium [57].  Finally, the administration of NG-nitro-L-arginine methyl ester during 
pregnancy induces a rise in blood pressure, which is reversed by CGRP [58,59], suggesting a 
compensatory role in this experimental preeclampsia model. 
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Adrenomedullin  
Adrenomedullin (ADM) was originally extracted from human pheochromocytoma [60], 
but is now known to be present in many organs.  ADM is a 52-amino-acid peptide sharing 
structural homology with CGRP. Together with amylin and calcitonin, ADM and CGRP are 
considered to belong to the same superfamily of peptides. Although less potent than CGRP, 
ADM has also vasodilator and hypotensive properties [61,62]. The circulating ADM plasma 
levels are elevated in human [63-66] and rat pregnancy [67]. Both progesterone and estradiol 
play a role in the regulation of mRNA expression of ADM [68,69] and its receptor 
components [70] in the pregnant uterus. In rat the administration of ADM has a stronger 
hypotensive effect in pregnancy than in the nonpregnant state [71]. Furthermore, ADM 
resembles CGRP in attenuating the NG-nitro-L-arginine methyl ester-induced rise in blood 
pressure in late-pregnant rat [71]. In early rat pregnancy ADM gene expression is raised in 
aorta, renal artery and kidney [72]. Finally, because of deviant plasma levels in preeclampsia 
relative to uneventful pregnancy, it has been suggested that ADM plays a role in the 
pathogenesis of this disorder. This role, though, ought to be complex as in preeclampsia both 
higher [73-75] and lower circulating levels of ADM [76] have been reported to occur. Never-
theless, it has been observed that a normally functioning ADM system is a prerequisite for 
normal fetal and placental growth [77,78]. 
 
Nitric oxide, acetylcholine, sodium nitroprusside, vasoactive intestinal peptide, substance P  
The enzyme NO synthase (NOS) catalyzes the formation of NO from the amino acid     
L-arginine. One of the isoforms of this enzyme ‒ eNOS ‒ is located in the endothelium and is 
involved in the regulation of the cardiovascular system [79]. In sheep [80], rat [81] and 
human [82] uterine artery eNOS expression and NO release are upregulated by pregnancy. 
NO is an important second messenger in the vasculature and therefore, contributes indirectly 
to the hemodynamic and volume adaptation to pregnancy. Inhibition of NOS during rat 
pregnancy induces a fall in glomerular filtration rate and plasma volume [83-89]. However, 
NOS inhibition did only partly abolish the difference between pregnant and nonpregnant rats 
in mean blood pressure, mesenteric perfusion pressure, and renal perfusion pressure [90,91]. 
Furthermore, prolonged inhibition of NOS in pregnant rat led to hypertension, proteinuria, 
thrombocytopenia, reduced plasma volume and fetal growth restriction [83,85]. Data about 
the contribution of NO to the blunted pressor and enhanced vasodilator responses in the 
vasculature during pregnancy are conflicting and in general limited to advanced pregnancy. 
The difference between pregnant and nonpregnant rats in pressor responses to phenylephrine 
persisted during NOS inhibition in thoracic aorta [92], but disappeared completely in uterine 
arteries [93]. Although NOS blockage led to a stronger renal vasoconstrictor response to 
angiotensin II in both pregnant and nonpregnant rats, the lower angiotensin II response in 
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pregnancy was preserved [90,91]. In advanced rat pregnancy NO also attenuated the pressor 
response of interlobar renal arteries to phenylephrine [94]. Inhibition of NOS reduced the 
vasoconstrictor response to electrical field stimulation (EFS) of mesenteric arteries in late-
pregnant rat [95]. However, the reduced responses to vasopressin and endothelin were 
endothelium-independent [95]. During guinea pig pregnancy, renal and mesenteric arteries 
were found to be more sensitive to the vasodilator properties of acetylcholine. NOS blockade 
abolished this effect in the renal - [96] but not in the uterine arteries [97]. Finally, pregnancy 
in women did not alter the endothelium-dependent relaxing response of small subcutaneous 
arteries to acetylcholine [98]. On the other hand, pregnancy enhances the acetylcholine-
induced vasodilatation of uterine arteries, a difference probably mediated by NO [99]. In 
myometrial arteries from pregnant women, flow-induced shear stress modulates vascular tone 
by NO and endothelin [100,101]. Interestingly, NOS blockade did neither abolish this effect 
on resting nor on stimulated forearm vascular resistance [102]. In conclusion, in advanced rat 
pregnancy NO is involved in renal and uterine vasodilatation. In human pregnancy, NO seems 
to contribute to the pregnancy-specific vasodilatation by its enhanced shear-stress dependent 
release in certain regions of the vascular bed. Therefore, it is more likely that NO is involved 
in maintaining rather than in inducing the pregnancy-related vasorelaxation. 
Acetylcholine is widely accepted to act as an endothelium-dependent vasodilator 
involving, among others, endothelium-derived NO. Sodium nitroprusside, on the other hand, 
is frequently used as an NO-donor substance. Data on vasoactivity of acetylcholine and 
sodium nitroprusside in pregnancy are inconsistent. There is neither evidence for pregnancy 
altering the vasodilator properties of acetylcholine [22,95,103] and sodium nitroprusside [95] 
in rat mesenteric arteries, nor for pregnancy modulating the relaxation of human subcutaneous 
fat resistance arteries in response to these agonists [98]. On the other hand, uterine artery 
[99,104,105] and thoracic aortic rings in late-pregnant rat did respond stronger to acetyl-
choline than in the nonpregnant state [106], an effect not accompanied by a change in the 
response to sodium nitroprusside [93].  Also, pregnancy was found to enhance the relaxing 
response of guinea-pig mesenteric arteries to acetylcholine [96]. These data support the 
concept that pregnancy may alter the vascular response to acetylcholine in selective regions of 
the vasculature.  
Little is known about the role of vasodilators as vasoactive intestinal peptide (VIP) and 
substance P in pregnancy. In one study VIP was found to induce uterine vasodilatation [107], 
whereas in another study the postmenopausal hypo-estrogenic state was found to correlate 
with a reduced content of both VIP and substance P in the uterine artery wall [108]. Whether, 
and if so, how changes in sex steroids during pregnancy modulate the activity of these 
vasodilators is unknown. 
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1.3 VASOCONSTRICTOR NERVES AND PEPTIDES: SYMPATHETIC NERVES, 
NORADRENALINE, ANGIOTENSIN, ARGININE VASOPRESSIN  
 
Sympathetic nerves and noradrenaline 
The uterus was the first organ to be explored for changes in sympathetic innervation 
during pregnancy. It was shown that pregnancy induced both degenerative [109-112] and 
regenerative changes [113] in sympathetic innervation of this organ. Later the role of steroids 
in the decrease of uterine arterial sympathetic activity was established in pig [114] and sheep 
[15]. More recently also in women, pregnancy was reported to lower the sympathetic 
response of uterine arteries to electrical field stimulation [115]. Meanwhile, in mesenteric 
veins of pregnant rat, transmural sympathetic nerve stimulation induced a smaller response, 
whereas exogenous noradrenaline triggered a larger response [116] suggesting hyper-
sensitivity secondary to reduced sympathetic innervation. In rat pregnancy, arterial pressor 
responsiveness to noradrenaline has been reported to be either blunted [90,117-119] or 
unchanged [95,120]. Moreover, these pregnancy-dependent changes show a profound 
regional variation with blunted responses in the mesenteric artery and unchanged responses in 
the arcuate [121] and renal [91] arteries. It is important to emphasize that these studies were 
all performed in late-pregnant rat. Finally, in normal human pregnancy peripheral sympathetic 
activity appears to be raised [122], a condition that seems to evolve into sympathetic hyper-
activity in pregnancy-induced hypertension and preeclampsia [123,124]. 
 
 
Angiotensin II  
In rat, pregnancy has been found to blunt the systemic arterial response to angiotensin II, 
in vitro ‒ in mesenteric [90,117] and uterine [104,105] arteries ‒ as well as in vivo ‒ in a 
perfused renal preparation [91]. In both normal and spontaneously-hypertensive pregnant rats, 
inhibition of  NOS did not abolish this Angiotensin II-mediated effect [91,125], suggesting 
that these blunted responses are NO-independent. It has been suggested that the activation of 
the renin-angiotensin system (RAS) in pregnancy contributes to the down regulation of AT-
receptors [126]. Interestingly, the higher RAS activity in pregnancy [1,3] coincides with the 
onset of early-pregnancy vasorelaxation. It is unclear, whether these two early changes are 
causally related. 
 
Arginine vasopressin (AVP) 
Information on the effect of pregnancy on AVP activity is scarce. Although late-pregnant 
rat mesenteric arteries elicit a lower response to AVP than nonpregnant mesenteric arteries 
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[90,95], this difference was not found in small omental arteries of late-pregnant women with 
an uneventful pregnancy [127,128].  
 
All the factors summarized in the introduction seem to play a role in the vascular 
adaptation to pregnancy. It is obvious that we have only limited insight in the complex 
sequence of events and interdependence of the effects induced by these factors, which 
culminates into systemic vasorelaxation. Most of the experimental data from the animal 
studies mentioned in the introduction were obtained in late pregnancy. Therefore, it is unclear 
if they are really involved in the initiation of early-pregnancy vasorelaxation. To further 
explore the mechanism that leads to this phenomenon of systemic vasodilatation in early 
pregnancy, we have tried to answer the following questions: 
• Is the hormonal environment created by steroids of luteal origin the sole prerequisite 
for the induction of early-pregnancy vasorelaxation? 
• If so, are the potent vasodilators CGRP and ADM, known to be mediated by the sex 
steroids, involved in early pregnancy vasorelaxation? 
• Are the pregnancy-dependent blunted vasoconstrictive responses typical for late 
pregnancy also found in early pregnancy? And are they mediated by the second 
messenger NO? 
 
This thesis consists of five independent studies designed to explore mechanisms leading to 
early-pregnancy vasorelaxation:  
1. The first study (chapter 2) was designed to explore the possible uterine and trophoblastic 
contributions to early-pregnancy vasorelaxation and also intended to confirm the 
importance of steroids in this process. 
2. The second study (chapter 3) focuses on the vascular reactivity to CGRP in early 
pregnancy, in particular, on the role of elevated circulating potassium levels on sensory-
motor nerves and the possibility of pregnancy-related changes in CGRP availability from 
the vascular wall. 
3. The objective of the third study (chapter 4) was to unravel the underlying mechanism of 
the raised vasodilator reactivity to CGRP in pregnancy relative to the nonpregnant state. 
We intended to generate experimental evidence for one of the following three possible 
explanations: diminished degradation of CGRP by matrix metalloproteinase-2, a rise in 
CGRP-receptor density, or effect-augmenting changes in the post-receptor CGRP-signal-
transduction pathway. 
4. ADM belongs to the same family of peptides as CGRP. Therefore, the fourth study 
(chapter 5) was designed to explore (1) the vascular reactivity of ADM in early preg-
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nancy; (2) the modulating effect of ADM on sympathetic and sensory-motor nerves and 
(3) the interaction between CGRP and ADM receptors. 
5. The fifth study of this thesis (chapter 6) elaborates on the pregnancy-dependent atte-
nuated vascular response to sympathetic stimuli, noradrenaline, vasopressin and 
angiotensin II. The emphasis of this study is on how NO and vascular remodeling impacts 
the vasoconstrictive reactivity in pregnancy. 
6. The general discussion is presented in chapter 7 and intends to integrate all observations 
and data reported in the literature in a unifying concept explaining our current ideas about 
the mechanism of early-pregnancy vasorelaxation. 
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ABSTRACT 
 
Hemodynamic changes in early pregnant and pseudopregnant rats are comparable, 
indicating that the trophoblast does not contribute to these changes. It is unclear whether the 
presence of the uterus is needed for the normal early-pregnancy hemodynamic adaptation. In 
this study we tested the hypothesis that uterine factors do not contribute to the systemic 
hemodynamic changes in early pseudopregnancy. To this end, we studied systemic 
hemodynamics in conscious pseudopregnant rats subjected to a hysterectomy, and compared 
these results with those obtained in a control group of pseudopregnant rats. The animals were 
studied on days 4, 8, 12 and 19 postmating.  
 On day 8 of pseudopregnancy, cardiac output has increased by 23±7% in the hys-
terectomized group and 15±5% in the control group. In both groups this rise in cardiac output 
was entirely accomplished by a rise in stroke volume, by 28±8% and 19±5%, respectively. 
Mean arterial pressure did not change appreciably. Therefore, total peripheral resistance also 
decreased in both groups (17±6%) by day 8. After day 12 the hemodynamic parameters 
returned to baseline. 
We conclude that systemic hemodynamic changes in hysterectomized pseudopregnant 
rats closely resemble those in intact pseudopregnant rats. Therefore, the uterus does not seem 
to play a role in these changes. This supports the hypothesis that only hormones from ovarian 
origin trigger the initial hemodynamic adaptation to early pregnancy. 
 
 
INTRODUCTION 
 
Hemodynamic changes in the pregnant woman can already be observed by the 5th week 
of human pregnancy [4,12]. These changes include a rise in cardiac output by approx. 20% 
above the nonpregnant value, mostly as a result of a rise in stroke volume [9,16]. A fall in 
mean arterial pressure and a rise in plasma volume [4] accompany the rise in cardiac output. 
The pregnancy-associated rise in cardiac output seems to develop in response to a fall in 
peripheral vascular resistance which in turn, results from systemic vasodilatation [4,5,9]. The 
functional contribution of these changes to pregnancy is still obscure. However, their 
importance is emphasized by the fact that the defective development of these adaptive 
changes in early pregnancy has been found to precede complications of pregnancy, such as 
fetal growth restriction and preeclampsia [10]. The underlying mechanisms as well as the 
factors that trigger these changes are obscure. In human pregnancy, the endocrine changes in 
the period between implantation and luteo-placental shift are orchestrated by the interplay 
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between corpus luteum and trophoblast. The synchronicity of the latter changes and those in 
hemodynamics suggests a causal relationship. However, neither the independent contribution 
of the two endocrine systems nor the mechanism by which they may trigger the institution of 
the high flow/low resistance circulation of pregnancy is understood [3,5]. 
Changes in systemic hemodynamics [18] and the hormones 17β-estradiol (E2), 
progesterone and prolactin [11,15,21] in early rat pregnancy are comparable with those in 
early human pregnancy. Meanwhile, in the rat the state of pseudopregnancy mimics early 
pregnancy in many aspects. Pseudopregnancy in the rat is a condition characterized by 
persistence of the endocrine function of the corpus luteum and lasts for a period of up to 12-
14 days [1,7]. During the first 9-10 days of this period, the patterns of change in the 
circulating levels of the sex steroids and prolactin [1,8,11,21] on the one hand, and those in 
hemodynamics on the other hand [14,19] are comparable with those in normal early rat 
pregnancy. This observation supports the view that, at least in the rat, the trophoblast plays a 
negligible role in this particular adaptation. However, this does not exclude the possibility that 
the luteal hormones trigger the typical pregnancy-like hemodynamic changes by acting in 
concert with an unknown factor of endometrial or myometrial origin. That is to say, does the 
uterus by releasing some vasoactive factor contribute to the induction of the hemodynamic 
changes of (pseudo)pregnancy? This possibility is plausible, knowing that the secretory 
endometrium is a production site of prolactin, relaxin and insulin-like growth factor-binding 
protein [17], all substances with vasoactive properties. If the latter possibility can be rejected, 
it is highly likely, that the early-pregnancy institution of a high flow / low resistance circu-
lation is entirely orchestrated by ovarian hormones only.  
Rats become readily pseudopregnant, even after hysterectomy. The latter induces a state 
of prolonged pseudopregnancy, in which the hormonal changes do not differ appreciably from 
those observed in normal pregnancy as well as from those in pseudopregnancy [7,15]. The 
present study was designed to test the hypothesis that the hemodynamic changes in early 
pseudopregnancy develop exclusively in response to changes in the circulating levels of 
ovarian hormones. To this end, we determined the pattern in systemic hemodynamic changes 
in conscious hysterectomized pseudopregnant rats and compared the data with that in intact 
conscious pseudopregnant rats.  
 
 
 
 
 
 
CHAPTER 2 
________________________________________________________________________ 
 
23 
 
METHODS 
 
Animal preparation 
This study was performed in female Wistar rats at the age of 3-4 months. After arrival 
from the external supplier (Charles River, Sulzfeld, Germany) the animals were allowed to 
acclimatize to our laboratory facility for at least 1 week before surgery. They were kept on a 
12h/12h light/dark cycle with free access to standard chow (Hope Farms, Woerden) and tap 
water. The animals were subdivided into two groups, with one group being subjected to 
hysterectomy (study group, n=7) and the other to a sham procedure (control group, n=6). 
Surgery was performed aseptically under general anesthesia, induced by ketamine (40 mg/kg) 
with xylazine (4 mg/kg).  The rats allocated to the study group underwent a bilateral 
hysterectomy by exposing the uterus through a mid-line abdominal incision. The uterus was 
dissected by ligation just proximal to the cervix and at the uterotubal junction. The rats in the 
control group underwent a sham procedure, which consisted of an abdominal incision only. 
After the surgical procedure the animals were housed in individual cages and allowed to 
recover from surgery for a period of at least two estrus cycles. Then pseudopregnancy was 
induced by allowing them to mate with a vasectomized male.  
The presence of a vaginal sperm plug was considered as day 1 of pseudopregnancy. The 
latter state was subsequently confirmed by the cessation of the estrus cycle (assessed by the 
persistence of the leucocytic vaginal smear). The instrumentation was performed on day 1 of 
pseudopregnancy. After the induction of anesthesia we performed a right-side thoracotomy 
under positive pressure respiration entering the thorax via the third intercostal space. After 
separating the ascending aorta from its surrounding tissue, we fitted an electromagnetic flow 
probe (2.3 mm Skalar, Delft, The Netherlands) around the aorta approx. 3-4 mm above the 
aortic valves as detailed previously [18,22]. Then, a polyethylene catheter (0.28 mm ID, 0.61 
mm OD) was advanced into the abdominal aorta from one of the femoral arteries. Both probe 
cable and catheter tip were tunneled subcutaneously and exteriorized from the neck, where 
they both were also sutured to the skin. 
The interruption of estrus cycle typical for pseudopregnancy was confirmed by daily 
vaginal smears. All measurements were performed on day 4, 8, 12 and 19 of pseudo-
pregnancy. The Ethical Board of the University of Maastricht approved all facilities and 
procedures. 
 
Experimental measurements 
To avoid the influence of diurnal variation on hemodynamics [13], we studied all animals 
at the same time of the day (between 10:00 and 15:00 h). Before data acquisition blood pres-
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sure transducer (Statham pressure transducer, Oxnard, CA, USA) and electromagnetic flow 
meter (Skalar instruments, Delft, The Netherlands) were calibrated. For the measurement of 
aortic flow, we assumed end-diastolic aortic flow to be zero at the site of the flow probe, since 
the latter was located just above the heart. After connecting the arterial catheter and the flow 
probe to the measurement devices, the animals were allowed to adjust to the experimental 
setup for 60 min. After this data were recorded for 90-120 min. Mean values were stored on 
hard disk every 30 s after on-line analysis by a real-time data system. From the flow signal, 
cardiac output (minus coronary flow, ml/min), heart rate (bpm) and stroke volume (ml) were 
derived. Systolic pressure, diastolic pressure and mean arterial pressure (mmHg) were 
recorded from the arterial pressure signal. From these indices total peripheral vascular 
resistance (mmHg·ml–1·min) and stroke work (mmHg·ml), an indictor of the energetic 
expense of blood imposed by the left ventricle per stroke were calculated. Catheter 
obliteration interfered with the blood pressure recording in some rats on days 12 and 19 of 
pseudopregnancy.  
 
Statistical analysis 
Data on day 4 were defined as baseline, as previous studies showed that on that particular 
day the hemodynamic function in pregnant and pseudopregnant rats does not differ 
appreciably from that in nonpregnant rats [18,19]. Furthermore, hemodynamics between the 
control and study group was not statistically different on that day (Mann-Whitney U-test). 
The longitudinal pattern in the various parameters throughout the measurement period in the 
two groups was analyzed by two-way analysis of variance by ranks (Friedman Test). In 
addition, we compared the absolute data and the percentage change relative to the 4th day, be-
tween the two groups on days 8, 12 and 19 using Mann-Whitney U-test with Bonferroni-
Hochberg correction. Intra-group differences between the observations on days 8, 12 and 19 
on the one hand, and day 4 of pseudopregnancy on the other hand, were analyzed by 
Wilcoxon Signed Rank-Test with Bonferroni-Hochberg correction. Data are expressed as 
means±SE unless stated otherwise. 
 
 
RESULTS 
 
Mean body weight at the onset of pseudopregnancy was 230±21 g and 236±25 g 
(means±SD) in the control and study group, respectively. Post-surgical weight loss was 
always less than 5%. Duration of pseudopregnancy assessed by the persistence of a leucocytic 
vaginal smear was 12±2 days in control and 17±1 (means±SD) days in hysterectomized rats. 
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The hemodynamic data in the two groups are listed in table 1, whereas patterns of change 
in cardiac output, stroke volume, total peripheral vascular resistance and stroke work are 
illustrated in figures 1 and 2. On pseudopregnancy day 8, cardiac output had increased by 
15±5% (control) and 23±7% (study) above the reference value of day 4 (p<0.05; figure 1).  
This rise in cardiac output resulted entirely from a rise in stroke volume (p<0.05; figure 
1) by 19±5% (control) and 28±8% (study), respectively, since the concomitantly measured 
heart rate had not changed appreciably (day 8). In both groups, the raised cardiac output on 
day 8 persisted until day 12, to return gradually to baseline afterwards, together with the other 
hemodynamic indices. In both groups we noticed a gradual decrease in heart rate after day 8. 
 
 
 
 
 
 
Table 1. Cardiovascular observations in control - and hysterectomized pseudopregnant rats 
 
Pseudopregnancy  Day 4 Day 8 Day 12 Day 19 
CO (ml/min) C 
S 
  67±5 
  66±7 
 
   76±8* 
   80±9* 
    74±5* 
    76±7* 
 61±6 
 69±3 
HR (beats/min) C 
S 
  433±26 
  444±27 
 
 423±16 
   426±22* 
    382±17* 
    393±11* 
   361±23* 
  370±8* 
SV (ml) C 
S 
152±9 
  147±23 
 
   180±16* 
   190±27* 
  194±5* 
    194±17* 
169±8 
  184±10 
n 
 
C 
S 
6 
7 
 
6 
7 
6 
7 
5 
5 
MAP (mmHg) C 
S 
102±7 
  96±8 
 
 97±4 
 96±6 
105±4 
104±7 
- 
- 
TPR (mmHg·ml-1·min) C 
S 
   1.53±0.23 
   1.50±0.17 
 
  1.25±0.06 
  1.23±0.20 
     1.36±0. 09 
    1.38±0.19 
- 
- 
SW (mmHg·ml) C 
S 
 14.3±3.5 
 15.7±0.8 
 
 18.2±3.5 
   18.0±1.9* 
    20.0±1.4* 
    20.2±0.8* 
- 
- 
n  
 
C 
S 
5 
5 
5 
5 
5 
5 
- 
- 
 
Values are means±SD. n, number of rats; HR, heart rate; CO, cardiac output; SV, stroke volume; MAP, mean 
arterial pressure; TPR, total peripheral vascular resistance; SW, stroke work.  
Each variable was subjected to two-way analysis of variance by ranks (Friedman test).  
Pseudopregnant sham group (control group; C): p<0.01 for HR; p<0.05 for CO, SV, TPR and SW.  
Pseudopregnant hysterectomized group (study group; S): p<0.01 for HR and SV; p<0.05 for CO and SW.   
*P<0.05 compared with day 4 by Wilcoxon’s signed rank test. 
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Since mean arterial pressure did not change consistently throughout the measurement 
period, the rise in cardiac output on days 8 and 12 was accompanied by a 17±6% fall in, total 
peripheral vascular resistance in both groups (figure 2). Figure 2 also depicts the percentage 
change in stroke work. In both groups this variable had increased relative to day 4. 
Throughout pseudopregnancy none of these variables differed between the control and study 
groups.  
 
Fig. 1. Percent changes relative to day 4 in cardiac output (CO) and stroke volume (SV) in intact - 
(control group; ) and hysterectomized pseudopregnant rats (study group;). Values are given as 
means±SE. An asterix (*) indicates that in both groups the observations at days 8 and 12 had changed 
significantly relative to day 4 (p<0.05). 
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DISCUSSION 
 
Changes in hemodynamics, renal function and volume homeostasis as well as endocrine 
changes do not differ appreciably between early pseudo – and early normal rat pregnancy 
[1,2,7,15,18,20,21]. Therefore, the pseudopregnant rat seems to be an attractive model to 
explore the mechanism of early-pregnancy vasodilatation. Our previously reported finding 
Fig. 2. Percent changes relative to day 4 in total peripheral vascular resistance (TPR) and stroke work 
(SW) in intact - (control group; ) and hysterectomized pseudopregnant rats (study group;). Values 
are given as means±SE. An asterix (*) indicates that in both groups the observations at days 8 and 12 had 
changed significantly relative to day 4 (p<0.05). (At day 8 the SW had changed significantly only in the 
control group.)  
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[19] that pseudopregnant and normal pregnant rat show a comparable systemic vasodilatation, 
supports a negligible role of the throphoblast in the development of this particular effect. 
However, this observation does not rule out the possibility, that luteal hormones induce their 
hemodynamic effects indirectly or in concert with some concomitantly released vasoactive 
substance from the myometrium or endometrium.  
Obviously, comparable hemodynamic changes in pseudopregnant and normal pregnant 
rat do not imply that the throphoblast is entirely irrelevant for the development of these 
changes. Firstly, only pseudopregnancy is self-limiting after approx. 10-12 days. Secondly, 
the rat does not have a luteo-placental shift. In contrast to human pregnancy, removal of the 
corpus luteum at any time in rat pregnancy is followed by abortion. These differences 
between human and rat pregnancy indicate that the mechanism of vasodilatation in the 
pseudopregnant rat model does not have to be exactly similar to that in human pregnancy. In 
the present study we found that the hemodynamic changes in pseudopregnancy were 
preserved after hysterectomy. In both groups cardiac output had increased by day 8 of 
pseudopregnancy, by a comparable selective rise in stroke volume. Although the data suggest 
a slower return to baseline of at least the stroke volume in the study group, we did not find 
any intergroup differences before day 12 of pseudopregnancy. The limited number of obser-
vations in our study after day 12 makes it difficult to interpret the influence of prolonged 
pseudopregnancy on hemodynamics. Others [7,15] have also reported the prolongation of 
pseudopregnancy by almost a week in hysterectomized rats. However, the lack of differences 
between the two groups in the first 12 days of pseudopregnancy makes it unlikely that the 
uterus has an appreciable influence on the presumed endocrine stimulus for the hemodynamic 
changes typical for this period. This is also supported by reports on progesterone levels during 
the first 10 days in intact and hysterectomized pseudopregnant rats [7,15].  
In our study, the animals in both groups showed a gradual decline in heart rate in the 
course of the study period. In previous studies with identical instrumentation and 
measurement procedures, we observed a similar pattern in heart rate in pregnant, 
pseudopregnant and control rats [18,19]. In this context, it is important to emphasize that the 
initial heart rate in the present study as well as in our previous studies was higher than 
corresponding values reported by others, using less extensive or no instrumentation. Most 
likely the initially higher heart rate in the present study reflects a higher sympathetic tone in 
the post-surgical recovery period as a consequence of our extensive instrumentation. The 
decline in heart rate over the subsequent days in all studies mentioned can be considered a 
combination of recovery and habituation to our experimental protocol. Although it is possible 
that a change in heart rate induced by pseudopregnancy was not identified because of the 
experiment-related tachycardia, the latter did not seem to have interfered with the changes in 
cardiac output and blood pressure in early pseudopregnancy. The fact that the comparable fall 
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in heart rate without concomitant fall in cardiac output was also observed in nonpregnant 
animals after the same extensive instrumentation [18] supports our view that the rise in 
cardiac output in pseudopregnancy is primarily due to a rise in stroke volume. 
Our results in intact and hysterectomized pseudopregnant rats indicate that neither the 
trophoblast nor the uterus is needed for the development of the vasodilatory response. 
Therefore, these results support our hypothesis that only hormones from ovarian origin trigger 
the systemic vasodilatation. Obviously, to explore the mechanism responsible for the he-
modynamic changes in early pregnancy, it is important to know the exact contribution of the 
independent ovarian hormones to these changes. To this end, the pseudopregnant rat may 
prove to be an attractive model in which hormonal and hemodynamic data can be studied at 
the same time. 
In summary, the present data suggest that, until day 12 post-mating, there is no difference 
in hemodynamic changes between intact and hysterectomized pseudopregnant rats. These 
hemodynamic changes are similar to the ones observed in early pregnancy and include 
peripheral vasodilatation, a rise in cardiac output by a selective rise in stroke volume and 
stroke work. Therefore, neither conceptus nor uterus seems to play a critical role in the 
induction of the initial hemodynamic adaptation to early pregnancy. The change in ovarian 
function resulting in a rise in sex steroids is the most likely mechanism responsible for this 
adaptation. How the sex steroids and possibly other ovarian hormones such as relaxin [6] 
initiate systemic vasodilatation remains to be elucidated. 
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ABSTRACT  
 
The objective of the present study was to determine the effect of early pregnancy on the 
sensitivity to, and endogenous production of Calcitonin Gene-Related Peptide (CGRP). 
Contractile responses of arteries of 10-day pregnant and nonpregnant rats were studied in 
myographs. During contractions induced by 40 mmol/l K+, exogenous CGRP elicited in 
pregnancy an approx. 30% stronger relaxation in mesenteric arteries, an effect not seen in 
renal and uterine arteries. Capsaicin treatment during K+-induced contractions caused a per-
sistent potentiation of the contractile response in mesenteric arteries indicating that K+ 
stimulates the endogenous release of CGRP. This potentiation was similar in the pregnant and 
nonpregnant state (+81±23% and +82±23%, respectively), suggesting no effect of pregnancy 
on the endogenous CGRP release. The latter was paralleled by comparable CGRP content in 
the arteries of both groups indicating similar tissue CGRP availability.  
The results of this study support the concept that early pregnancy is associated with a rise 
in the vascular sensitivity to CGRP in selected areas of the vascular bed without concomitant 
increase in the vascular CGRP production and release.  
 
 
INTRODUCTION 
 
Early pregnancy is associated with marked hemodynamic changes, which include a rise 
in cardiac output and plasma volume, a fall in peripheral systemic vascular resistance and 
hemodilution. These changes seem to represent compensations for a primary fall in systemic 
vascular tone. The latter phenomenon is observed not only in human – [1,2], but also in rat – 
[3] and sheep pregnancy [4]. Although the functional meaning of the systemic vasorelaxation 
in pregnancy is still obscure, its importance for pregnancy is emphasized by the 
epidemiological observation that hypertensive complications of pregnancy such as 
preeclampsia and fetal growth restriction (IUGR) are preceded by the defective development 
of this adaptive vascular response to pregnancy [5]. Therefore, we expect that exploration of 
the mechanism responsible for the early-pregnancy vasorelaxation will improve our 
understanding of the pathogenesis of hypertensive complications in pregnancy. 
Calcitonin Gene-Related Peptide (CGRP) is a 37-amino-acid vasoactive neuropeptide 
that is mainly expressed in the dorsal root ganglia. It is the most potent endogenous 
vasodilator and is released from the sensory-motor nerves, which are distributed throughout 
the cardiovascular system. In the rat [6,7] the hypotensive effect of CGRP is enhanced in late 
pregnancy possibly as a result of a higher vascular sensitivity to CGRP. Whether CGRP con-
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tributes to the vasorelaxation in early pregnancy is unknown. Elevated peripheral CGRP 
levels in both rat - [8] and human pregnancy [9,10] support the view that CGRP is involved in 
the regulation of vascular tone in pregnancy.  
The objective of this study was to test the hypothesis that the vasorelaxation in early 
pregnancy is also caused by an increased vascular sensitivity to CGRP. To this end, we 
studied in a myograph the vasodilator effects of exogenous CGRP on K+-induced contractions 
in different types of rat arteries. By using capsaicin [11], a vanilloid pungent, that initially 
stimulates and subsequently desensitizes and destroys the sensory-motor nerves, we also 
determined the vasorelaxant response of endogenous CGRP released from perivascular 
sensory-motor nerves.  
 
 
MATERIAL AND METHODS 
 
Preparation 
The present study was carried out on arteries of 3‒4-month-old female Wistar rats (Iffa 
Credo, Someren, The Netherlands). We subdivided the animals (n=20) into equal-sized 
groups of pregnant and nonpregnant rats. To establish pregnancy, we allowed the animals in 
the pregnant group to mate with a male rat. We defined retrieval of a sperm plug from the 
cage as confirmation of day 1 of pregnancy. On day 10 of pregnancy we sacrificed the rats by 
cervical dislocation and isolated a renal -, a uterine -, and a branch of the superior mesenteric 
artery. Segments (1.5-2 mm long) of these arteries were mounted on two stainless wires 
(diameter: 40 µm) in an isometric myograph (JP, Trading, Aarhus, Denmark) between an 
isometric force transducer (Kistler Morse, DSC6, Seattle, WA, USA) and a displacement 
device. The organ chamber (10 ml) of the myograph was filled with Krebs-Ringer bicarbonate 
solution (KRB, composition in mM: NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4·H2O 1.2, 
KH2PO4 1.2, NaHCO3 25.0 and glucose 5.5) which was maintained at 37°C and aerated with 
95% O2/5% CO2. Subsequently all arteries were distended to their individual optimal 
diameter, which was determined by increasing the lumen diameter by 50 μm (mesenteric and 
uterine artery) or 100 μm (renal artery) increments. Intermittently, contractile responses to 
maximal depolarization were induced by exposing the preparations to high potassium solution 
(K-KRB, KRB in which all NaCl was replaced by an equimolar amount of KCl). The 
diameter at which a maximal contractile response was obtained was considered to be the 
optimal diameter. All experiments were performed at this diameter. The same procedure was 
applied to arteries of nonpregnant female rats serving as control group. 
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Experimental protocol 
During a steady-state contraction induced by 40 mmol/l K+ we tested the response to 
exogenously applied human CGRP (0.1 to 100 nmol; Natick, MA, USA). Subsequently and 
during K+-induced contraction, we incubated the arteries with 1 µmol/l capsaicin (Sigma 
Chemical Co., St. Louis, MO, USA) during at least 20 min, in order to desensitize the 
sensory-motor nerves [11]. The neuro-excitatory effect of the vanilloid during this period was 
recorded. After this treatment the dose-response curve with CGRP was repeated. Between the 
different parts of the protocol the arteries were allowed to return to their basal tone by rinsing 
the drugs (figure 1). As we have reported previously [12], capsaicin neither influences basal 
tone nor does the induced desensitization of sensory-motor nerves result in a loss of 
postjunctional responses to exogenous CGRP.  
 
Immunohistochemistry 
The presence of sensory-motor nerves was demonstrated by staining arteries with rabbit 
anti-rat CGRP antibodies. The mounted arteries were fixed overnight in the myograph organ 
bath in phosphate-buffered (pH 7.4) formaldehyde (4%) at room temperature, followed by 
storage in 70% ethanol. Blockade of endogenous peroxidase activity was achieved by 
incubation at room temperature in 0.3% H2O2 for 2 h. Subsequently, the preparations were 
washed with 70% ethanol and then treated with Triton X-100 (0.2% in PBS), before overnight 
incubation with 1:3000 diluted primary antibody (Amersham) at room temperature. Then, the 
preparations were rewashed with Triton X-100 for 1 h, incubated with the secondary antibody 
(swine anti-rabbit peroxidase, 1:200; DAKO Immunoglobulins, Glostrup, Denmark) and 
washed once more with Triton X-100. Finally, preparations were incubated with 1.2 mmol/l 
diaminobenzidine and 0.03% H202 for 15 min at room temperature, dehydrated to xylene (30 
min), embedded in Entellan and finally examined and photographed using a Zeiss axioscope. 
 
CGRP-content 
After isolation the arteries are kept for 15 min in 1 ml boiling 0.5 M HCl. After removing 
the arteries CGRP is extracted and determined from this solution, using a CGRP RIA-kit 
(Peninsula). The arteries are placed in 200 μl 1 M KOH for 48 h at room temperature. This 
solution is used for DNA determination according to the Hoechst 33258-method [13]. CGRP 
content of the arteries is expressed as pg/μg DNA. 
 
Statistics 
Vascular reactivity was expressed as percent change of the maximal steady-state K+-
induced contraction. Sensitivity (given as the negative logarithm of EC50 = pD2) and maximal 
response (Emax) to CGRP were calculated by a square sigmoidal curve fit of the response 
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curves. Data are expressed as means±SEM. We evaluated differences between the pregnant 
and nonpregnant groups by Student’s t-test. A p-value of less than 0.05 was considered to 
indicate statistical significance. 
 
 
RESULTS 
 
Reactivity 
The mesenteric-, uterine- and renal arteries responded similarly to the application of 40 
mmol K+: an initial transient phase (figure 1) passing into a steady-state contraction persisting 
for at least 20 min. Exogenous CGRP during this steady-state contraction caused 
concentration-dependent relaxation in the mesenteric and uterine arteries. Concentration-
response analysis of the mesenteric artery disclosed a higher sensitivity (pD2) and a higher 
maximal response (Emax) to exogenous CGRP in early pregnancy than in the nonpregnant 
state (table 1 and figure 2). This difference was not observed in the uterine artery (table 1). 
The renal artery did not respond to exogenous CGRP in either pregnancy or the nonpregnant 
state (data not shown). Initially capsaicin (1 µmol/l) diminished the K+ induced contraction in 
mesenteric arteries (-61±7% pregnant group; -54±8% nonpregnant group) and in the uterine 
arteries (-39±7% pregnant group; -52±9% nonregnant group). After approximately 5 min this 
relaxing effect faded and the K+ induced contraction stabilized between 10 to 20 min as sign 
of complete desensitization of sensory-motor nerves (figure 1). Contractile responses to 40 
 
Fig. 1. Typical tracing of the effects on isometric tension development in isolated rat mesenteric artery 
(pregnant and nonpregnant) of 40 mmol/l K+ (horizontal bar), exogenous CGRP and capsaicin (1 µmol/l, 
CAP). At washout (W) the tissue was incubated in drug-free Krebs solution. 
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mmol K+ after the capsaicin pretreatment (figure 1) were significantly higher in mesenteric 
(+81±23% pregnant group; +82±23% nonpregnant group) and uterine arteries (+81±41% 
pregnant group; +101±37% nonpregnant group) compared to the responses before capsaicin 
pretreatment. These higher responses were not significantly different between the pregnant 
and nonpregnant group for both arteries. Renal arteries did not respond to capsaicin and the 
contractile response to K+ was not modified after treatment with the pungent. After capsaicin 
pretreatment, sensitivity and maximal response to exogenous CGRP were still higher in the 
mesenteric artery of the pregnant group than in the nonpregnant group (table 1 and figure 2).  
 
 
 
Table 1. Vascular reactivity to CGRP before and after capsaicin treatment. 
  Mesenteric artery  Uterine artery 
 N pD2 Emax  pD2 Emax 
Nonpregnant 10   8.45±0.21 40±6  8.73±0.17 70±7 
Pregnant 10 
 
11.03±0.91* 75±4*  8.67±0.29 78±3 
 Capsaicin treatment 
Nonpregnant 10   8.95±0.14 76±2  8.84±0.12 90±1 
Pregnant 10 10.97±0.78* 82±2*  9.28±0.26 90±2 
 
pD2 values (-Log Molar [EC50]) and Emax for the response to exogenous CGRP before and after capsaicin 
pretreatment for mesenteric and uterine arteries.  
Data are shown as mean±SEM. *p<0.05 with Student’s t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Relaxing responses to exogenous CGRP (0.1 to 100 nmol/l) during K+-induced contraction (40 
mmol/l) before and after pretreatment with capsaicin (1 µmol/l) in mesenteric arteries of pregnant (open 
circle) and non-pregnant (closed circle) Wistar rats.  
 
concentration CRGP (log M) 
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However, the difference in maximal response to exogenous CGRP diminished after this 
pretreatment (table 1 and figure 2). After capsaicin pretreatment there was still no difference 
in uterine vasodilator response to exogenous CGRP between the pregnant and nonpregnant 
group (table 1). Also, after exposure to capsaicin, renal arteries failed to respond to exogenous 
CGRP.  
 
Immunohistochemistry 
The density of CGRP-immunoreactive sensory-motor nerves was higher in the 
mesenteric and uterine arteries than in the renal artery (figure 3) with no appreciable change 
in pregnancy. 
 
CGRP content 
Table 2 illustrates the CGRP content of the three types of arteries.  Early pregnancy did 
not seem to have altered the arterial CGRP content. 
 
Fig. 3. Anti-CGRP immunohistochemistry in whole mount preparations of a mesenteric (A), uterine (B) 
and renal (C) artery of a 10-day pregnant Wistar rat. Note the absence anti-CGRP staining in the renal 
artery. 
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Table 2. CGRP-content of rat arteries 
 
 Mesenteric artery 
CGRP (pg/µg DNA) 
Uterine artery 
CGRP (pg/µg DNA) 
Renal artery 
CGRP (pg/µg DNA) 
Nonpregnant 32.6±2.50 18.7±1.54   9.8±1.85 
Pregnant 30.1±1.89 16.5±1.05 11.5±1.77 
 
CGRP content expressed as pg/µg DNA. The data are shown as mean ± SEM. Control group (n=6 for all 
three types of arteries), pregnant group (n=6 for all three types of arteries). 
 
 
 
 
DISCUSSION 
 
Our results clearly indicate that mesenteric arteries are more sensitive to exogenous 
CGRP at day 10 of pregnancy than in the nonpregnant state. We also demonstrated that K+-
induced contractile responses of arteries equipped with a dense network of CGRP-containing 
sensory-motor nerves, such as the mesenteric and uterine arteries, are effected by 
endogenously released CGRP. Several lines of evidence support this finding. First, in mesen-
teric and uterine arteries the sensory-motor nerve stimulating and desensitizing agent 
capsaicin [11] initially reduces and then potentiates the contractile response to K+. Second, 
relaxing responses to exogenous CGRP in mesenteric and uterine arteries are increased after 
capsaicin treatment. Therefore, it is likely that the observed K+-induced contraction before 
capsaicin is the combined response to K+ and to endogenously released CGRP. After 
capsaicin treatment endogenous CGRP is no longer released by the depolarizing stimulus and 
exogenous CGRP can gain access to its receptors on the arterial smooth muscle cells without 
competition by endogenous released neuropeptide. Third, neither the relaxing nor the potenti-
ating effects of capsaicin are seen in arteries with sparse perivascular sensory-motor nerve 
density such as the renal artery (this study) and the superior epigastric artery [14]. Fourth, a 
CGRP-receptor antagonist such as CGRP8-37 increases contractile responses to K+ in arteries 
densely innervated with perivascular sensory-motor nerves such as the mesentery [12].  
The increased sensitivity to exogenous CGRP in the mesenteric arteries of the pregnant group 
was preserved after desensitization of the sensory-motor nerves by capsaicin. The difference 
in maximal dilatation between the pregnant and nonpregnant groups also persisted after 
pretreatment with capsaicin. These findings suggest that the difference between the pregnant 
and nonpregnant state cannot be explained by a difference at a prejunctional level, e.g. a 
higher density or CGRP-content of the perivascular sensory-motor nerves in pregnancy. This 
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conclusion is consistent with our data of the immunohistochemical and CGRP-content 
studies, which revealed no pregnancy-related change in sensory-motor nerve density or 
CGRP-content in the mesenteric arteries.  
Pregnancy and the sex steroids are known to raise peripheral CGRP levels in the human 
[9] and rat [8]. From the reported data it is not possible to discern whether these higher 
circulating levels of CGRP are to be explained by accelerated synthesis and/or excretion into 
the circulation by perivascular sensory-motor nerves or of diminished metabolization of 
CGRP. The equally potentiated response to K+ after capsaicin pretreatment in the pregnant 
and nonpregnant mesenteric artery (+81±23% and +82±23%, respectively) supports the 
concept that higher circulating levels of CGRP are probably secondary to attenuated clearance 
or as recently reported [15], increased release of CGRP by the nerve terminal. Obviously, it is 
also possible that capsaicin and K+ act via different pathways in releasing endogenous CGRP 
from the sensory-motor nerve endings but further detailed studies are required to explore this 
mechanism. 
We observed marked regional differences in sensitivity to the vasodilator effects of 
exogenous CGRP and its modulation by pregnancy. In contrast to the mesenteric artery, 
contractile and relaxing responses to K+, exogenous CGRP and capsaicin in the uterine 
arteries did not change in early pregnancy relative to the nonpregnant state. The renal arteries 
display only sparse perivascular sensory-motor innervation and did not respond to exogenous 
CGRP or capsaicin at all. The differences between these arteries and the mesenteric arteries 
could be explained by the fact that they are conduit and not resistance arteries. Although 
speculative, the different function and size of the latter could be associated with a difference 
in CGRP-receptor density or coupling. Therefore, one cannot exclude the possibility that 
further downstream the vascular beds of the kidney and the uterus the same pregnancy-related 
increase in sensitivity to exogenous CGRP could be obtained. At least in humans at term, sen-
sitivity to CGRP of segments of the uterine arteries was increased [16]. Furthermore, there is 
evidence that sex steroid supplementation in ovariectomized rats increases the fall in uterine 
perfusion pressure in response to CGRP [7].  
There is compelling evidence that CGRP is involved in the hemodynamic adaptation to 
pregnancy. The decrease in mean arterial pressure in response to CGRP is larger in pregnancy 
than in the nonpregnant state [6]. This response was also enhanced in ovariectomized rats 
treated with progesterone or estradiol. Induction of hypertension by inhibition of nitric oxide 
production (L-NAME) in pregnant rats could be reversed by infusion of CGRP [17] and again 
this effect seemed to be progesterone dependent [18]. These studies suggest an altered effect 
of CGRP on vascular resistance in pregnancy, that is to say an increase in sensitivity to 
CGRP. However, all these data were obtained in rats at a gestational age of 19 days, while 
systemic vasorelaxation leading to the pregnancy-related hemodynamic changes takes place 
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in early pregnancy. Therefore, it is difficult to extrapolate the results of these earlier studies to 
the regulation of vascular tone in early pregnancy. In rat pregnancy, cardiac output increases 
by approx. 20% by the 10th day of pregnancy, without any change in vascular structure [19]. 
This means that our results, suggesting a higher sensitivity to CGRP in mesenteric arteries by 
10 days pregnancy, are not paralleled by the confounding influence of vascular remodeling.  
The mechanism by which pregnancy modulates the effect of CGRP on vascular tone is 
unknown. The vasodilator effect of CGRP involves the endothelium, activation of K+-
channels in the arterial smooth muscle and activation of adenylate cyclase [20]. Unpublished 
data of our group reveal that the relaxing effects of exogenous CGRP in rat mesenteric 
arteries were not modified by the removal of endothelium and thus they appear to be nitric 
oxide independent. This is in agreement with previous findings [16,21] and the fact that 
CGRP completely reversed L-NAME induced hypertension in pregnant rats [17,18]. We 
studied the relaxing responses of CGRP in the presence of 40 mmol K+. This excludes the 
possibility that the difference in response between the pregnant and nonpregnant groups is 
due to a difference in sarcolemmal K+ channels. Activation of adenylate cyclase takes place 
through G-protein coupled CGRP receptors. Increased concentration or affinity of these re-
ceptors may be involved in the mechanism leading to an increased sensitivity to CGRP in 
pregnancy.  Recent studies demonstrating the up-regulation of CGRP receptor concentration 
and binding in human and rat uterus in pregnancy [22,23] support this hypothesis. 
Progesterone is thought to play a crucial role in this process [23]. Whether or not CGRP 
receptor concentration or the coupling of CGRP receptors to adenylate cyclase is changed in 
resistant arteries in early pregnancy remains to be elucidated. 
In summary, our results confirm the hypothesis that resistance artery sensitivity to CGRP 
in pregnancy is increased. This change can already be detected in 10-day pregnant rats, and is 
regionally selective. Further, our results indicate that early pregnancy is not associated with a 
change in perivascular density of sensory-motor nerves or CGRP-content. Thus, CGRP may 
play a role in the early-pregnancy vasorelaxation and hemodynamic adaptation during 
pregnancy. The mechanism responsible for the increased vasodilator response of CGRP in 
pregnancy and the assumed role of the sex steroids in this process remains to be established. 
Our data support the view that the latter effect could be secondary to a higher density and/or 
function of postjunctional receptors. 
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ABSTRACT 
 
The objective of this study was to explore the mechanism responsible for the higher 
relaxing responses of mesenteric arteries to calcitonin gene-related peptide (CGRP) in 
pregnancy. We performed myograph and ligand binding studies to determine the role of 
matrix metalloproteinase-2 (MMP-2) and the CGRP-receptor density. MMP activity was 
manipulated in isolated arteries by exposing them to the blocking effects of doxycycline. 
Vascular activity of MMP-2 was studied by gelatin zymography and CGRP receptor density 
was determined by ligand binding analysis. As compared to nonpregnancy, CGRP elicited 
stronger arterial relaxation in pregnancy. The latter effect was neither accompanied by a 
change in relaxing responses to direct activation of adenylyl cyclase by forskolin, nor by a 
change in the response to stimulation of G-protein coupled adrenergic receptors by 
isoproterenol. Doxycycline did not affect the stronger arterial relaxation in pregnancy in spite 
of the observed more than 3-fold higher arterial MMP-2 activity. Density of binding sites for 
[125I]CGRP in arteries from pregnant rats (64±14 fmol/mg protein) and from virgin rats (54±5 
fmol/mg protein) were comparable. The results of this study provide evidence for increased 
coupling of CGRP-receptors to adenylyl cyclase in early pregnancy. 
 
 
INTRODUCTION 
 
In most mammals, including rat [1,2] and man [3-5], pregnancy induces systemic 
vasorelaxation. Various observations support an important role for CGRP in triggering this 
phenomenon [6,7]. CGRP is a 37-amino-acid vasoactive neuropeptide. After its release from 
sensory-motor nerves, it acts as a potent vasodilator throughout the cardiovascular system [8]. 
Recently, we demonstrated higher vasodilator responses to exogenous CGRP in mesenteric 
resistance arteries of early-pregnant rats relative to nonpregnant control rats [9]. The 
mechanism leading to this effect was unclear.  
In human [10] and rat pregnancy [11], the circulating levels of CGRP are elevated. 
Whether this rise and the development of a stronger CGRP vasodilator activity result from a 
shared pregnancy-related mechanism, is unknown. In early-pregnant rat, we did not find a 
higher density of perivascular sensory-motor nerves nor an enhanced content of CGRP in the 
wall of the mesenteric arteries [9], suggesting no accelerated synthesis or release of CGRP by 
the sensory-motor nerve endings. However, a lower metabolic clearance of CGRP in preg-
nancy could also result in higher CGRP levels in the direct vicinity of sensory-motor nerves. 
In this context, MMP-2 could be important, because this enzyme inactivates endogenous 
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CGRP [12]. It follows that a condition-specific inhibition of MMP-2 activity in early preg-
nancy could explain the higher circulating levels of CGRP as well as a higher CGRP activity 
in the vascular bed. To our knowledge, the role of MMP-2 as a modulator of the neurohor-
monal activity of CGRP in early pregnancy has not been addressed. 
Besides the latter mechanism for a more pronounced effect of CGRP in pregnancy, it is 
also conceivable that CGRP activity in the vascular bed is higher in pregnancy in conjunction 
with upregulation of the CGRP receptors.  
This study was designed to test the hypothesis that in early pregnancy arterial vaso-
dilatation in selected areas results from a stronger CGRP effect due to a condition-specific fall 
in vascular MMP-2 activity, possibly potentiated by a concomitant rise in the density and 
affinity of CGRP receptors. To test this hypothesis, we studied the effect of exogenous CGRP 
on K+-induced contractions in mesenteric arteries from both nonpregnant and pregnant rats 
and assessed, whether the MMP inhibitor doxycycline amplified these effects in pregnancy to 
a higher degree than in the nonpregnant state. In addition, we determined the MMP-2 activity 
in the arterial wall by gelatin zymography. The possible contribution of CGRP receptor 
upregulation was addressed by ligand-binding studies in isolated intact mesenteric resistance 
arteries.  
 
 
MATERIAL AND METHODS 
 
Preparation 
The present study was carried out in 3‒4-month-old female Wistar rats (Iffa Credo, 
Someren, The Netherlands). The animals (n=20) were divided into two subgroups of pregnant 
(n=10) and nonpregnant rats (n=10). To establish pregnancy, we allowed the animals in the 
pregnant group to mate with a male rat. The retrieval of a sperm plug from the cage confirmed 
the first day of pregnancy. On day 10 of pregnancy we sacrificed the rats by cervical 
dislocation and isolated a first order branch of the superior mesenteric artery. Segments of 
these arteries (1.5-2 mm long) were mounted on two stainless wires (diameter: 40 µm) in an 
isometric myograph (JP Trading, Aarhus, Denmark) between an isometric force transducer 
(Kistler Morse, DSC6, Seattle, WA, USA) and a displacement device. The organ chamber (10 
ml) of the myograph was filled with Krebs-Ringer bicarbonate solution (KRB, composition in 
mM: NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4·H2O 1.2, KH2PO4 1.2, NaHCO3 25.0 and glu-
cose 5.5) which was maintained at 37°C and aerated with 95% O2/5% CO2. Then, we 
distended the arteries by increments of 50 μm to their optimal lumen diameter. Intermittently, 
we induced contractile responses to maximal depolarisation by exposing the preparations to 
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high potassium solution (K-KRB, KRB with NaCl replaced by an equimolar amount of KCl). 
We defined the optimal diameter as the one that enabled the largest contractile response. All 
experiments were performed at this diameter. We also applied this procedure to the 
corresponding arteries of nonpregnant female rats, which served as controls. In both groups 
we prepared a second segment of the arteries in a myograph as described above, to create an 
identical set-up enabling the execution of parallel experiments. 
 
Experimental protocol 
Exposure of an artery with a high density of sensory-motor nerves to K+ not only induces 
a contractile response, but also causes the release of endogenous CGRP [9]. Therefore, the 
arteries in both settings were first incubated with 1 µmol/l capsaicin (Sigma Chemical Co., St. 
Louis, MO, USA) for at least 20 min. Initially, capsaicin stimulates the sensory-motor nerves, 
but prolonged exposure leads to persistent desensitization and destruction of these nerves 
[14]. The effect of capsaicin on K+-induced contraction was discussed in detail in our 
previous report [9]. In our hands this treatment results in a very stable, long lasting 
contraction without the possibility of interference by endogenous CGRP.  After this treatment 
we tested the response to exogenously applied human αCGRP (0.1 to 100 nmol; Natick, MA, 
USA) during a steady-state contraction induced by 40 mmol/l K+. Than, we incubated for a 
period of 20 min, the arteries in one of the 2 set-ups in media containing 20 nM doxycycline, 
thus blocking all MMP-2 activity, and repeated the experimental protocol with CGRP. 
Between the consecutive sections of the protocol, we allowed the arteries to return to their 
basal tone by rinsing the applied compounds. Subsequently, we conducted a dose-response 
curve for forskolin (0.01 to 100 nmol/l, Sigma Chemical Co., St. Louis, MO, USA), a direct 
activator of adenylyl cyclase. This experiment served as control for a possible difference be-
tween the pregnant and nonpregnant groups in the downstream cascade of signal transduction. 
That is to say, at the level of the contractile machinery in the vascular smooth muscle cell 
itself. Finally, we constructed dose-response curves for isoproterenol (0.01 to 100 nmol/l 
Sigma Chemical Co., St. Louis, MO, USA), an activator of adrenerge receptors. The latter 
consists ‒ similar as the CGRP receptor ‒ of a seven-transmembrane G-protein-coupled 
receptor. Therefore, a difference between pregnancy and controls in the relaxing response to 
both vasodilator agents would indirectly indicate a difference at the level of G-proteins. 
 
Ligand-binding 
Because of the use of intact arteries in the myograph, we decided to perform the analysis 
of [125I]CGRP binding in comparable arterial segments [15]. The arteries were obtained from 
pregnant (n=4) and nonpregnant (n=3) rats. After collection these segments were pooled and 
first incubated for 60 min at 37ºC in 250 μl 50 mM Tris-HCl, 5 mM MgCl2, 100 mM NaCl, 
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0.2% bovine serum albumin (pH 7.4) containing 100 to 2000 pM [125I]CGRP (Amersham 
Biosciences). In parallel incubations nonspecific binding was determined in the continuous 
presence of 2 μM CGRP. After incubation the arterial segments were placed over Whatman 
filters and washed 5 times with incubation buffer. Then the segments were recovered from the 
filters and dissolved in 100 μl 1 N KOH. Radioactivity was determined in a γ-counter 
(Wallace). Specific binding was calculated by subtracting nonspecific binding from total 
binding. The data were analysed with the scatchard method using 17 points for the control and 
20 points for the pregnant group. Finally, the protein content was analysed using bovine 
serum albumin as standard. Specific binding was expressed as CGRP bound to the protein 
content (fmol/mg BSA). 
 
Gelatin zymography 
We placed mesenteric arteries in ice-cold extraction buffer, which contained 10 mmol/ 
cacodylic acid, 150 mmol/l NaCl, 20 mmol/l CaCl2, 1 mmol/l ZnCl2, 1.4 mmol/l NaN3, 0.01% 
Triton for 48 h. The detergent-soluble fractions of the incubated tissues were retained and 
protein concentrations in the samples were equalized by using a Bicinchonine acid protein 
assay Then samples were rinsed with SDS-PAGE sample buffer, and applied to 10% SDS-
polyacrylamide gel, which contained 1 mg/ml gelatin, followed by separation using 
electrophoresis. By washing the gels twice with 2.5% Triton X-100, the SDS was removed. 
Subsequently, the gels were incubated overnight at 37ºC in zymography buffer (50 mmol/l 
Tris, 5 mmol/l CaCl2, 0.02% NaN3) and stained with Coomassie brilliant blue G250 in 40% 
methanol and 10% acetic acid. Gelatinolytic activity was visualized as clear areas of lysis in 
the gel. Densitometric analysis was performed by using the Leica Image Processing and Ana-
lysis system. Gelatin zymographic analysis revealed multiple lytic bands with the presence of 
the pro-form of MMP-2 at 72 kDa and the active form at 64 kDa.  
 
Statistics 
We expressed vascular reactivity as percentage change of maximum steady-state K+-in-
duced contraction. Sensitivity (represented by the negative logarithm of EC50 = pD2) and 
maximum response (Emax) to CGRP were calculated by a square sigmoidal curve fit of the 
concentration response curves. We calculated specific binding of [125I]CGRP in terms of 
maximal density (Bmax) and affinity (KD). MMP-2 activity in the arteries of pregnant animals 
was expressed as a percentage of the activity in the control group. Data are presented as 
means±SEM. We evaluated differences between the pregnant and nonpregnant groups by 
two-way analysis of variance (ANOVA) followed by t-test using Bonferroni method to 
correct for multiple testing. We considered a p-value of less than 0.05 to indicate statistical 
significance. 
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RESULTS 
 
Reactivity 
Mesenteric resistance arteries of pregnant and nonpregnant rats responded similarly to 
stimulation with 40 mmol K+. A first transient contraction was followed by a smaller steady-
state contraction. The amplitudes of both phases were comparable between the arteries of 
pregnant and nonpregnant rats (data not shown). As we have reported previously [9] the 
application of capsaicin (1 μmol/l) induces a rapid and transient decline in the K+-induced 
contraction in conjunction with the release of CGRP from the sensory-motor nerves. After 
approx. 5 min this decline fades over an interval of 10 to 20 min to give way to a new and 
higher steady-state contraction as compared to the one during the pretreatment period, 
reflecting the condition of complete desensitization of the sensory-motor nerves.  
Administration of exogenous CGRP during the K+-induced steady-state post-capsaicin 
contraction caused a concentration-dependent relaxation in mesenteric arteries of both the 
pregnant and nonpregnant rats. Both the sensitivity (pD2) and the maximum response (Emax) 
were significantly larger in the pregnant - as compared to the nonpregnant rats (figure 1, table 
1). Incubation of the arteries with doxycycline neither changed the relaxant responses to 
CGRP, nor abolished the difference between the pregnant and nonpregnant group (figure 2, 
 
Fig. 1. Relaxing responses to CGRP (0.1-100 nmol/l) during K+-induced contraction in mesenteric 
arteries of pregnant (open circle) and non-pregnant (closed circle) rats. p<0.05 for pD2; p<0.05 for Emax. 
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table 1). In contrast to CGRP, the relaxing effects of the diterpene ‘forskolin’ did not differ 
between the arteries of pregnant and nonpregnant rats (figure 3). The sensitivity and maximal 
relaxing responses of the mesentery artery to this compound that directly activates adenylyl 
cyclase were similar in pregnant and nonpregnant animals. The relaxing response to 
isoproterenol was even larger in the nonpregnant rats (figure 4), however, without significant 
difference in the derived parameters of the concentration-response curves.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. pD2 values (-log molar [EC50]) and Emax to exogenous CGRP before and after pretreatment with 
doxycycline in mesenteric arteries 
 
 PD2 Emax 
Non-pregnant 7.03±0.09 56±2 
Pregnant 8.40±0.33* 71±3* 
  after doxycycline 
Non-pregnant 8.11±0.20 39±1 
Pregnant 8.54±0.09* 68±13* 
 
Data are shown as mean±SEM. 
p<0.05. 
 
 
Fig 2. Relaxing responses to CGRP (0.1-100 nmol/l) during K+-induced contraction after incubation with 
doxycycline in mesenteric arteries of pregnant (open circle) and non-pregnant (closed circle) rats. p<0.05 
for pD2; p<0.05 for Emax. 
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Fig. 3. Relaxing responses for forskolin during K+-induced contraction in mesenteric arteries of pregnant 
(open circle) and non-pregnant (closed circle) rats. 
 
 
Fig. 4. Relaxing responses to isoproterenol during K+-induced contraction in mesenteric arteries of 
pregnant (open circle) and non-pregnant (closed circle) rats. 
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Ligand-binding 
Analysis of the specific binding of [125I]CGRP revealed a similar dissociation constant 
and density of specific binding sites in the pregnant (Kd=144 pM; Bmax=64±14 fmol/mg 
protein) and nonpregnant group (Kd=171 pM; Bmax=54±5 fmol/mg protein).  
 
Gelatin zymography 
Zymographic analysis of MMP-2 in mesenteric arteries indicated a more than threefold 
higher activity of the 64 kDa isoform of MMP-2 in pregnant - (352%) than in nonpregnant 
rats (100% by definition) (figure 5). 
 
 
Fig. 5. Expression of pro MMP-2 (72 kDa) and active MMP-2 (64 kDa) and its level in intact mesenteric 
arteries of pregnant and controls considering activity in the control group as 100% (C); *p<0.05. 
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DISCUSSION 
 
The results of this study are consistent with a higher responsiveness to exogenous CGRP 
of mesenteric arteries in 10-day pregnant rats relative to nonpregnant rats. A possible 
explanation for this effect is a higher availability of circulating CGRP to the vascular smooth 
muscle cells. In rat pregnancy peripheral levels of CGRP are higher than in the nonpregnant 
state [11]. However, it is not clear whether the latter results from accelerated 
synthesis/excretion or reduced metabolization of CGRP. Recently, we have demonstrated that 
mesenteric arteries of both pregnant and nonpregnant rats have a dense network of CGRP-
containing sensory-motor nerves with comparable CGRP content [9]. There is some indirect 
evidence for an elevated release of CGRP from perivascular sensory-motor nerves in near-
term rat pregnancy [16]. In this study and our recent report [9] we demonstrated a higher 
arterial responsiveness to CGRP after incubation with capsaicin in pregnancy as compared to 
the nonpregnant state. Although this observation opposes the possibility of higher mesenteric 
artery responsiveness to CGRP in pregnancy due to a higher release of endogenous CGRP, it 
does not exclude the possibility of increased CGRP availability for its receptors in 
conjunction with a slower metabolic clearance.   
MMP-2 is one of the key enzymes in trophoblast invasion and placentation, with in-
creased expression in trophoblast cells in the first trimester [17,18]. In rat uterine arteries 
MMP-2 activity is enhanced particularly in late pregnancy [19], on the other hand 
progesterone is known to down-regulate MMP-2 [20]. MMP-2 is also a modulator of vascular 
function by its capacity to cleave CGRP, which will promote vasoconstriction [12]. In this 
study, inhibition of MMP-2 by doxycycline did not change the response to exogenously 
applied CGRP in mesenteric arteries of pregnant and nonpregnant animals. Not only was the 
effect of doxycycline on the vascular reactivity to CGRP in pregnancy, negligible, we also 
demonstrated a markedly elevated MMP-2 activity in the mesenteric artery already in early 
pregnancy as compared to the nonpregnant state. Although MMP-2 is able to promote 
vasoconstriction in mesenteric arteries of rats, the specific cleavage responsible for this effect 
only takes place after hours and this effect is mainly demonstrated after incubation with 
exogenous MMP-2 [12]. Even the high endogenous MMP-2 level in pregnancy, apparently 
does not change the short-term effect or metabolic clearance of circulating CGRP. Instead, 
pregnancy is associated with higher circulating levels of CGRP [11]. One can only speculate 
on the effect of MMP-2 on the CGRP level in pregnancy. However, only strong inhibition of 
MMP-2 activity in pregnancy could be responsible for a higher release of CGRP. The 
existence of such mechanism in pregnancy is unknown and from a physiological point of 
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view unlikely. Our data taken together do not support a role for MMP-2 in the pregnancy-
dependent rise in arterial responsiveness to CGRP 
The vasodilator effect of CGRP is achieved by mechanisms that are both endothelium-
dependent and independent [8,21]. However, the involvement of nitric oxide in the changes in 
CGRP reactivity in pregnancy seems negligible [22,23]. The other mechanisms by which 
CGRP modulates vascular tone involve the activation of K+ channels and the stimulation of    
adenylate cyclase, resulting in an increase of cyclic AMP in arterial smooth muscle cells [21]. 
Both these mechanisms play a role in the vasodilating response to CGRP in late pregnancy 
[24]. A third mechanism, the accumulation of cGMP was also demonstrated in pregnancy 
[24]. However, there is convincing evidence that the latter is an endothelium-dependent effect 
mediated by increased synthesis of NO [25] and therefore seems not to be responsible for the 
changes in pregnancy. 
We studied the relaxing responses to CGRP in the presence of a high concentration K+. 
Because of the almost identical response to K+ in both the pregnant - and nonpregnant states, 
it is highly unlikely that the difference in vasodilator response to CGRP between the pregnant 
and nonpregnant states can be explained by a difference in activated outward potassium chan-
nel current. 
The other signal transduction mechanisms trigger the accumulation of cyclic AMP by 
stimulation of adenylate cyclase by G-protein coupled CGRP receptors. Our results clearly 
indicate that the direct activation of adenylyl cyclase by forskolin or stimulation of other G-
protein coupled receptors, as the adrenergic receptors does not alter the vasodilator response 
in pregnancy relative to the nonpregnant state. Therefore, we conclude that the difference in 
vasodilator response between pregnancy and nonpregnancy is the result of a difference at the 
level of the CGRP receptors rather than a difference downstream the signal transduction path-
way. 
CGRP receptors are characterized by a complex structure with still obscure regulation 
during pregnancy. Based on recent observations CGRP receptors can be subdivided into 
CGRP-A and CGRP-B receptors [26]. CGRP-A receptors consist of a seven transmembrane 
G-coupled protein, a so called calcitonin receptor-like receptor (CRLR). When CRLR binds 
to the accessory protein, receptor activity modifying protein (RAMP1) its biological behaviour 
resembles that of a CGRP-A receptor [27,28].  In mesenteric arteries of pregnant rats mRNA 
levels of CRLR only increase after day 18 [13], whereas those of RAMP1 have been reported 
to increase more gradually from early pregnancy onward [13]. The latter would be consistent 
with our data, which suggest that CGRP binding sites have not increased appreciably by day 
10 of pregnancy. Whether the RAMPs are involved in the increased arterial responsiveness to 
CGRP in pregnancy, is still obscure. Another factor that is still unsettled is the role of CGRP-
receptor component (RCP). Unlike RAMP, which acts more as a chaperone in the CGRP-
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receptor complex, RCP allows direct coupling to the intracellular signaling pathway [29,30]. 
It is unknown whether the level or function of RCP in pregnancy is changed. However, with 
unchanged CGRP receptor density or a postreceptor signaling pathway, it is possible that 
changes in receptor coupling modulated by changes in RCP or RAMP are responsible for the 
increased relaxing responses to CGRP in pregnancy.  
In summary, pregnancy induces a rise in the mesenteric artery responsiveness to CGRP, 
which appears unrelated to a higher MMP-2 activity, CGRP-receptor density or changes in 
the intracellular signaling pathway. Whether the pregnancy-specific rise in vasodilator activi-
ty is a consequence of increased coupling secondary to changes in RCP or RAMP requires 
further study.  
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ABSTRACT 
 
The objective of this study was to determine whether the vascular response to adre-
nomedullin is modulated by pregnancy. To this end, we studied the effect of adrenomedullin 
on different contractile responses of mesenteric, uterine, renal and saphenous arteries of 10-
day pregnant and nonpregnant rats in myographs. Adrenomedullin inhibited contractile 
responses induced by electrical field stimulation (EFS) only in the mesenteric and uterine 
arteries. This effect was more pronounced during pregnancy than in the nonpregnant state. 
Adrenomedullin did not modify concentration response curves to noradrenaline. The 
reduction of contractile responses to 40-mmol/l K+ by adrenomedullin was similar in arteries 
of pregnant and nonpregnant rats. However, after incubation with capsaicin this effect was 
significantly increased in mesenteric arteries of the pregnant group.  
We conclude that pregnancy is associated with a rise in the prejunctional inhibitory effect 
of adrenomedullin in some regions of the arterial system.  
 
 
INTRODUCTION 
 
Adrenomedullin is a vasorelaxing hypotensive peptide, initially isolated from human 
pheochromocytoma [1], and has also been retrieved from other human tissues such as the 
adrenal glands, heart and kidneys. Detectable peripheral levels of adrenomedullin, mainly 
produced by vascular smooth muscle cells, support a role as a vasodilator hormone [2]. 
Circulating plasma adrenomedullin levels are elevated in a wide range of disease states, 
including cardiovascular, renal and endocrine disorders [3].  
The normal hemodynamic adaptation to pregnancy includes a rise in cardiac output and a 
fall in total peripheral resistance [4,5]. In the rat these changes can already be detected at day 
10 of pregnancy [6]. This state of a high flow-low resistance circulation is accompanied by a 
decreased arterial responsiveness to vasoconstrictors and sympathetic nerves [7]. Whether 
adrenomedullin is involved in these changes is obscure. During pregnancy circulating levels 
of adrenomedullin are higher than in the nonpregnant state [8-11], partly due to placental pro-
duction of the peptide [12]. Higher plasma levels of adrenomedullin in pregnancy relative to 
the nonpregnant state have also been found in the rat [13].  This suggests that the rat may be a 
suitable model to study the possible role of adrenomedullin in the vasodilator response to 
pregnancy.   
The present study was designed to determine in the rat, the effect of pregnancy on arterial 
responses to exogenous adrenomedullin. To this end, we assessed the responsiveness to 
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adrenomedullin in isolated mesenteric, renal, uterine and saphenous arteries obtained from 
nonpregnant and from 10-day pregnant Wistar rats. Because of the close relationship of 
adrenomedullin to calcitonin gene-related peptide [3] and the use of a common receptor, we 
also studied its effect on sensory-motor nerves. 
 
 
MATERIAL AND METHODS 
 
Animals and arteries 
We performed our experiments in isolated arteries of 3‒4-month-old virgin and pregnant 
rats (approx. 250 g, Iffa Credo, Someren, The Netherlands). After arrival from the supplier, 
the animals were housed in individual cages and the ones allocated to the pregnant group 
(n=8) were allowed to mate. We defined the first day of pregnancy as the day of sperm plug 
retrieval. On the tenth day of pregnancy, the animals were sacrificed by cervical dislocation 
and exsanguination. The virgin rats (controls, n=5) were sacrificed at a corresponding day 
after arrival in our laboratory facility. We removed by careful dissection under the dissection 
microscope, a renal, uterine and saphenous artery and a first order branch of the superior 
mesenteric artery. These choices were inspired by the different contributions of different 
vascular beds to the pregnancy-related hemodynamic changes [14] and regional differences in 
autonomic control of the vessel wall [15]. That is to say, the mesenteric artery represents the 
systemic circulation the uterus is the target organ of the changed circulation, while the kidney 
plays an important role in hemodynamic regulation. The saphenous artery serves as a control 
vessel. Segments of these arteries (1.5-2 mm long) were mounted on two stainless wires (40 
µm) in an isometric myograph (JP Trading, Aarhus, Denmark) connected between a force 
transducer (Kistler Morse DSC6, Seattle, WA, USA) and a displacement device for the re-
cording of isometric tension development. The organ chamber (10 ml) of the myograph was 
filled with Krebs-Ringer bicarbonate solution (KRB, composition in mM: NaCl 118.3, KCl 
4.7, CaCl2 2.5, MgSO4·H2O 1.2, KH2PO4 1.2, NaHCO3 25.0 and glucose 5.5), maintained at 
37ºC and aerated with 95% O2/5% CO2. Each arterial segment was stretched to its own 
optimal lumen diameter, which was determined by a stepwise increase of the lumen diameter 
in 50 µm (mesenteric, uterine and saphenous artery) or 100 µm (renal artery) increments and 
induction of contractile responses to depolarization with 40 mmol/l potassium solution (K-
KRB, KRB in which part of the NaCl was replaced by an equimolar amount of KCl).  We 
performed all our experiments at the optimal lumen diameter of each artery. The Ethics 
Committee for the Use of Experimental Animals of the University of Maastricht approved the 
experimental procedures. 
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Experimental protocol 
We induced contractile responses of the mounted arteries by stimulating perivascular 
sympathetic nerves using EFS (90 V, 4-32 Hz) at basal tone. For this purpose we used two 
platinum electrodes along the axial direction of the arterial segment. This stimulation leads to 
contraction of vessels only with and not without sympathetic nerves [16].  In rat mesenteric 
arteries these contractile responses are abolished by 1 μmol/l tetrodotoxin, 1 μmol/l 
guanethidine and 300 μmol/l 6-hydroxydopamine and are reduced for more than 95% by 1 
μmol/l prazosin, indicating sympathetic stimulation [16]. The arteries were exposed to 
adrenomedullin (Peninsula laboratories, Belmont, CA, USA) by administering the compound 
to the organ chamber of the myograph for a period of 10 min. Afterwards, we repeated the 
vasoconstrictor response to EFS followed by a recovery period, to allow the artery to return to 
baseline and to rinse the adrenomedullin. By a stepwise increase in the concentration of 
adrenomedullin (0.1 to 100 nmol/l) in between a series of EFS as specified above, we were 
able to quantify the adrenomedullin-dependent inhibition of the sympathetic vasoconstriction.  
Subsequently, the same experiment was run again, but instead of EFS, concentration 
response curves for exogenous noradrenaline (10 nmol/l-10 µmol/l) were conducted and thus 
used to define the postjunctional vasodilator effect of adrenomedullin. Concentrations of 
adrenomedullin and the design of the experiment were identical to the protocol as described 
above.  
Finally, a third type of contractile response was induced by adding 40 mmol/l K+ to the 
organ chamber. During a steady-state contraction the vasodilator response to adrenomedullin 
(0.1 to 100 nmol/l) was tested. As we have demonstrated recently, K+-induced contractile 
responses are modulated by endogenous calcitonin gene-related peptide [17], a strong 
vasodilator peptide, released by perivascular sensory-motor nerves. In order to investigate the 
role of these sensory-motor nerves we repeated this last experiment after incubation of the 
arteries during 20 min with 1 μM capsaicin, a vanilloid pungent that irreversibly desensitizes 
the sensory-motor nerves [18], resulting in an augmentation of the K+-induced contraction. 
 
Data analysis 
We expressed the magnitude of the arterial response as wall tension (isometric force 
divided by twice the segment length). We calculated the vasodilator response to 
adrenomedullin as a percentage of the initial response to EFS, as percentage of the initial 
response to noradrenaline or as percentage of the steady-state contraction induced by 40 
mmol/l K+. The latter response curves were further analyzed by a square curve fit to calculate 
pD2 and Emax. Data are shown as means±SEM. Differences in vascular response between 
pregnant and nonpregnant animals were evaluated by ANOVA with repeated measurements. 
A p-value below 0.05 was considered statistically significant.  
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RESULTS 
 
Mechanical properties and effects of early pregnancy vasoconstrictor responses to EFS, 
noradrenaline and K+ 
Optimal lumen diameter did not differ between pregnant and nonpregnant rats for 
mesenteric (287±17 and 294±19 μm), uterine (276±6 and 280±15 μm) renal (741±21 and 
767±35 μm) and saphenous arteries (355±15 and 367±9 μm). EFS and noradrenaline induced 
a frequency- and concentration-dependent vasoconstrictor response in all four types of 
arteries. Pregnancy attenuated the contractile response to EFS of mesenteric arteries (figure 
1A) and, only for the lower EFS frequencies, of uterine arteries (figure 1B). These differences 
were not observed in the renal and saphenous arteries. Responses to noradrenaline and K+ 
were comparable between both groups for all types of arteries.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Vasoconstrictor responses expressed as wall tension of (A) mesenteric and (B) uterine arteries of 
control (closed circles; n=5) and pregnant (open circles; n=8) rats to electrical field stimulation (4-32 Hz, 
90 V) at basal tone. 
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Effect of adrenomedullin on vasoconstrictor responses 
Exogenous adrenomedullin reduced the sympathetic contractile responses of EFS in 
mesenteric and uterine arteries of pregnant and nonpregnant rats (figure 2a and b). This effect 
was dose-dependent, but for all concentrations stronger in pregnancy than in the nonpregnant 
state (tables 1 and 2). After rinsing all of the compound, EFS elicited a comparable 
contraction as the initial one excluding a time-dependent effect. Neither in the renal, nor in 
the saphenous arteries did adrenomedullin elicit a significant reduction of the sympathetic 
constrictor responses in either the pregnant or nonpregnant group (figure 2c and d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Fig. 2 (a and b). Response curves to EFS (4-32 Hz, 90 V) in the absence (closed circles) and presence 
(open circles) of 100 nmol/l adrenomedullin in control and pregnant rats in (a) mesenteric and (b) uterine 
arteries. *p<0.05 indicates a significant reduction of responses in the presence of adrenomedullin. 
 
2a 
2b 
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Table 1. Percentage of baseline contractile response of mesenteric arteries to EFS (4-32 Hz, 90 V) in the 
presence of 1 to 100 nmol/l adrenomedullin. Data are expressed as mean±SEM.  
 
Frequency 1 nmol/l  
adrenomedullin 
 10 nmol/l 
adrenomedullin 
 100 nmol/l  
adrenomedullin 
 control pregnancy  control pregnancy  control pregnancy 
4   Hz    92±19  93±35  69±32 29±24  60±23 23±22 
8   Hz    98±10  89±19  76±12 45±19  53±12 32±13 
16 Hz 108±7  79±8*   83±10   38±12*  96±24   29±10* 
32 Hz 109±7 92±8   96±13 62±16  92±20 52±14 
*p<0.05 indicates a significant difference between the control and pregnant group. 
  
  
2c 
2d 
Fig 2 (c and d). Response curves to EFS (4-32 Hz, 90 V) in the absence (closed circles) and presence 
(open circles) of 100 nmol/l adrenomedullin in control and pregnant rats in (c) renal and (d) saphenous 
arteries. *p<0.05 indicates a significant reduction of responses in the presence of adrenomedullin. 
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Table 2. Percentage of baseline contractile response of uterine arteries to EFS (4-32 Hz, 90 V) in the presence 
of 1 to 100 nmol/l adrenomedullin. Data are expressed as mean±SEM. 
 
Frequency 1 nmol/l  
adrenomedullin 
 10 nmol/l  
adrenomedullin 
 100 nmol/l  
adrenomedullin 
 control pregnancy  control pregnancy  control pregnancy 
4    Hz  109±28   68±21    97±25  23±7*  70±26 19±10 
8    Hz  108±19   79±14    99±17 37±8*  55±22      23±6 
16  Hz     109±7   80±9*  103±7   55±14*  78±16  37±12 
32  Hz 106±5 103±7  106±6       85±9  88±14  71±14 
*p<0.05 indicates a significant difference between the control and pregnant group. 
 
 
Neither in the pregnant nor in the nonpregnant group did we observe a consistent effect 
of exogenous adrenomedullin on the concentration response curves to noradrenaline in any of 
the four types of arteries (figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
3a 
 
Fig. 3 (a and b). Response curves to noradrenaline (10 nmol/l-10 µmol/l) in the absence (closed circles) 
and presence (open circles) of 100 nmol/l adrenomedullin in control and pregnant rats in (a) mesenteric 
and (b) uterine arteries.   
 
3b 
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At a steady-state K+-induced contraction adrenomedullin elicited vasodilator responses in 
mesenteric and uterine arteries (figure 4A and C). Again we did not observe any response to 
adrenomedullin in the renal or saphenous arteries in either pregnant or nonpregnant rats (data 
not shown). The vasodilator responses observed in the mesenteric and uterine arteries did not 
differ significantly between the pregnant and nonpregnant state (figure 4A and C). However, 
after incubation with capsaicin the reduction of maximal constriction by adrenomedullin was 
significantly stronger in mesenteric arteries of pregnant rats (pD2 10.12±0.12 versus 
9.77±0.25, p<0.05; Emax 29±5 versus 66±5, p<0.05; figure 4B).   
 
  
  
3c 
3d 
Fig. 3 (c and d). Response curves to noradrenaline (10 nmol/l-10 µmol/l) in the absence (closed circles) 
and presence (open circles) of 100 nmol/l adrenomedullin in control and pregnant rats in (c) renal and (d) 
saphenous arteries.   
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DISCUSSION 
 
The fall in vascular tone that develops in early pregnancy may be triggered either by 
reduced vascular responsiveness to vasoconstrictors, or by increased vascular responsiveness 
to vasodilators, or by a change in plasma levels of these agents. A combination of these 
effects is also possible. A well-known feature of normal pregnancy is the lower pressor 
responsiveness to vasoconstrictors such as angiotensin II, noradrenaline and vasopressin 
[7,19] and to selective sympathetic nerve stimulation [7]. We suppose the latter to be a 
prejunctional effect because in our hands there was no difference in response to noradrenaline 
between the groups. This effect may thus involve changes in the prejunctional control of 
transmitter release. Such mechanisms are less effective at a high level of sympathetic 
  
  
Fig. 4. Effect of various concentrations adrenomedullin (0.1 to 100 nmol/l) on a K+-induced contraction 
of mesenteric arteries, of control (closed circles) and pregnant (open circles) before (A) and after (B) 
incubation with capsaicin and of uterine arteries before (C) and after (D) incubation with capsaicin. 
*p<0.05 for pD2  and  #p<0.05 for Emax. 
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stimulation [20]. This could explain the fact that the significant lower uterine arterial 
responsiveness in pregnancy was only demonstrated for the lower frequencies of EFS. These 
data are in line with other findings [7] revealing also no significant difference at high 
frequencies between the pregnant and nonpregnant group. 
The reported data on the responsiveness to vasodilators of non-uterine vessels in preg-
nancy is limited [7]. Therefore, it is still unclear, whether vasodilators contribute to the 
pregnancy-induced systemic vasorelaxation. In pregnancy, the circulating plasma level of 
adrenomedullin is higher than in the nonpregnant state [8,11,21]. In addition, the cytotropho-
blast releases adrenomedullin already in the post-implantation period [22]. These observations 
suggest that this vasodilator could be involved in the early-pregnancy vasodilatation. For this 
reason, we used adrenomedullin to test the hypothesis that increased vascular responsiveness 
to vasodilators contributes to the systemic vasorelaxation in early pregnancy.  
Our findings are in line with the previously reported rise in vascular sensitivity to 
adrenomedullin during pregnancy [23,24]. They document for the first time that this is 
already the case at mid-pregnancy and because of the selective effect of EFS it must involve 
increased sensitivity of sympathetic nerves to the inhibitory action of the peptide in some but 
not all vascular beds. In the mid-pregnant rat, adrenomedullin elicits a higher vascular 
response of the mesenteric and uterine arteries than seen in the nonpregnant rat during 
sympathetic stimulation. Especially in the uterine artery we were not able to demonstrate a 
different response to the highest frequency with or without adrenomedullin between the 
groups. As stated before this may be the result of prejunctional control of neurotransmitter 
release [20]. In contrast with the vasodilator responses in the mesenteric and uterine artery, 
and irrespective whether the rats were pregnant or not, we did not find a response to 
adrenomedullin in the renal and saphenous arteries. Possibly these differences are related to 
the fact that the latter are conduit arteries, and therefore differ in diameter and function. 
However, one should also keep in mind, that the conduit characteristics of the renal and hind 
limb arteries may change towards resistance vessels downstream the microcirculation. In that 
case, the experimental data obtained in the larger upstream portions of the arteries are not 
representative for the entire arterial bed of the tissues supplied. Furthermore, the study of 
isolated vessels in pregnancy excludes the normal influence of a unique and complex 
endocrine environment, which is likely to play an important role [25]. 
It is of interest that adrenomedullin lacked effects on noradrenaline-evoked contractions, 
while blunting electrical field stimulation-induced responses. In view of the sympathetic 
nature of the field stimulation-induced contractions [16] this discrepancy indicates a 
prejunctional inhibitory effect of adrenomedullin on the sympathetic neurotransmission. As 
we have demonstrated, this effect is stronger in pregnancy compared to the nonpregnant state.   
In order to investigate whether adrenomedullin has a comparable effect on sensory- 
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motor nerves, its reactivity on K+-induced contractions was studied before and after 
incubation with capsaicin. As we have recently demonstrated [17] K+-induced contractions 
are modulated by calcitonin gene-related peptide released by perivascular sensory-motor 
nerves. Capsaicin selectively destroys these sensory-motor nerves [18] resulting in an 
augmentation of K+-induced contractions. Therefore, a modulating effect of adrenomedullin 
on sensory-motor nerve activity would have resulted in a rise of K+-induced contractions after 
incubation with capsaicin. However, we were unable to demonstrate such an effect. Instead, 
we found an increased response to adrenomedullin after incubation with capsaicin in 
mesenteric arteries of pregnant rats. Therefore, the effect of adrenomedullin during the K+-
induced contraction and its modulation by pregnancy suggests a postjunctional rather than a 
prejunctional effect. Together with adrenomedullin, calcitonin gene-related peptide is a 
member of the calcitonin gene-related peptide superfamily. Like adrenomedullin, calcitonin 
gene-related peptide is a potent vasodilator peptide, with an enhanced hypotensive effect in 
pregnancy [26,27]. Both peptides use the calcitonin-receptor-like receptor (CRLR), which can 
function as either a calcitonin gene-related peptide receptor or an adrenomedullin receptor, 
depending on the coupling to so called receptor-activity-modifying proteins (RAMPs).  CRLR 
may either bind to RAMP1 to form the CGRP-A receptor, or to RAMP2 or RAMP3 to form the 
adrenomedullin receptor [28]. In mesenteric arteries of pregnant rats the mRNA level for 
CRLR is stable throughout pregnancy with a sudden and significant increase at day 18 of 
pregnancy, whereas the mRNA level of RAMP1 is already elevated at day 5 of pregnancy 
[29]. Therefore, one can speculate on the regulation of receptor systems and the role of 
RAMPs in pregnancy and the possibility that sex steroids modulate this regulation. In this 
perspective, the augmentation of the vascular response of mesenteric arteries to 
adrenomedullin by pregnancy together with capsaicin is interesting. That is to say, in this 
setting only the absence of endogenously released calcitonin gene-related peptide leads to an 
increased vasodilator response to adrenomedullin in pregnancy. This is in favor of an in-
creasing availability of receptors to adrenomedullin. As early pregnancy is associated with a 
stable level of CRLR and increasing concentrations of RAMPs, it is likely that a change in 
coupling between the receptor and the different accessory proteins is responsible for this 
pregnancy-related change in vasodilator response. However, the exact contribution of receptor 
modulation by RAMPs to the vascular tone in early pregnancy requires further study. 
In summary, our results demonstrate that pregnancy is associated with an increased 
vasodilator response to adrenomedullin. At least part of this effect is caused by prejunctional 
inhibition of sympathetic nerves. This change can already be detected in 10-day pregnant rats 
and could be confined to resistance arteries. The mechanism responsible for the increased 
vasodilator response and the role of adrenomedullin receptors, RAMPs and sex steroids 
merits to be elucidated.  
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ABSTRACT 
 
The objective of this study was to determine, whether blunted vasoconstrictor responses 
in pregnancy are nitric oxide (NO)-dependent or a consequence of vascular remodeling. To 
this end, we studied the effect of NO on contractile responses to sympathetic nerve 
stimulation, noradrenalin, angiotensin II and vasopressin of mesenteric arteries of pregnant 
and non-pregnant rats in myographs. To evaluate the role of arterial remodeling by pregnancy 
on these contractile responses, we established morphometric properties of the arteries. 
Pregnancy attenuated the vasoconstrictor responses to electrical field stimulation, 
noradrenalin and angiotensin II but not that to vasopressin. This effect was not abolished by 
incubation of the arteries with NO. Pregnancy did not alter the morphometry of mesenteric 
arteries. We conclude that pregnancy is associated with blunted arterial responses to selective 
stimulation of sympathetic nerves, noradrenalin and angiotensin II. Neither NO nor structural 
morphometric changes of the arterial wall modifies these pregnancy-related changes. 
 
 
INTRODUCTION 
 
Hemodynamic changes in early pregnancy are characterized by a rise in cardiac output 
and plasma volume, a fall in peripheral vascular resistance [1,2] and hemodilution. These 
changes seem to develop secondary to a fall in systemic vascular tone and have been observed 
in human [3], rat [4] and sheep [5] pregnancy. Although the functional meaning of this 
phenomenon is still obscure, the observation that its defective development in the human is 
associated with poor placentation and hypertensive complications of pregnancy [3] 
emphasizes its importance. Although these complications only occur in the second half of 
pregnancy, vasorelaxation can already be detected by 5 weeks human pregnancy [3] and 8 
days rat pregnancy [4]. 
The mechanism responsible for the early-pregnancy vasorelaxation is still unclear. 
Several reports provide evidence that pregnancy in rat attenuates the constrictor response of 
isolated arteries to a wide range of agonists [6]. The agents tested sort their effect through 
different mechanisms of signal transduction, suggesting that the blunted vasoconstriction in 
pregnancy results from an effect on the common final pathway of the excitation-contraction 
coupling in the vascular smooth muscle cells [7]. Therefore, it is conceivable that the early-
pregnancy systemic vasodilatation develops in response to pregnancy-specific hormones such 
as relaxin [8] acting in concert with higher circulating levels of endothelium-derived vaso-
dilators such as nitric oxide [9,10]. 
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In this study, we tested the hypothesis that the blunted response to constrictor agents in early 
pregnancy is at least in part due to elevated intra-arterial levels of nitric oxide. To test this 
hypothesis, we determined concentration-response curves for various vasoconstrictor agonists 
and sympathetic nerve stimulation in mesenteric resistance arteries from nonpregnant and 10-
days pregnant rats, in the absence and presence of NG-nitro-L-arginine methyl ester (L-
NAME), an inhibitor of nitric oxide synthase. Finally, we compared the mesenteric artery 
structure in the pregnant with that in the nonpregnant rat to assess, whether arterial 
remodeling had contributed to the observed differences in response.  
 
 
MATERIAL AND METHODS 
 
Animals and arteries 
The Ethics Committee for the Use of Experimental Animals of the University of 
Maastricht approved the experimental procedures. The study was carried out on arteries of 
3‒4-month-old pregnant and nonpregnant Wistar rats (Iffa Credo, Someren, The 
Netherlands). The rats were housed in individual cages and handled in a standardized fashion, 
which includes a 12h/12h light/dark cycle and free access to standard rat chow (Hope Farms, 
Woerden, The Netherlands) and acidified water. Pregnancy was achieved by allowing the rats 
to mate with a male rat. The presence of a sperm plug was defined as the first day of 
pregnancy. At day 10 of pregnancy the animals were killed by cervical dislocation and 
exsanguination. At the same day after arrival in our laboratory facility, virgin ‘control’ rats 
were sacrificed similarly. A first order branch of the superior mesenteric artery was isolated 
under a dissection microscope. Arterial segments (2 mm long) were mounted on two stainless 
wires (diameter 40 µm) in an isometric myograph (JP Trading, Aarhus, Denmark) between a 
force transducer (Kistler Morse DSC6, Seattle, WA, USA) and a displacement device for the 
recording of isometric tension development. We kept the preparations in Krebs-Ringer 
bicarbonate (KRB) solution, at 37°C and aerated them with 95% O2/5% CO2. All arterial 
segments were stretched to their optimal lumen diameter by stepwise stretching them with 
increments of 50 µm. Maximal depolarization with high potassium solution (K-KRB) was 
used as activating stimulus. The diameter at which a maximal contractile response was 
obtained was considered to be the optimal diameter, at which all experiments were performed.  
 
Experimental protocol 
Concentration-response curves for noradrenaline, vasopressin, and angiotensin II were 
conducted at basal tone. After each experiment, the preparation was allowed to return to 
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baseline by rinsing the drug. We used electrical field stimulation (EFS; 90 V, 0.5-32 Hz) to 
activate perivascular sympathetic nerves [11]. Than, we incubated the arteries for 30 min in a 
solution of 100 µM L-NAME. Repeating the concentration-response curves for the different 
stimuli described above assessed the effect of L-NAME. Finally, we repeated the EFS after 
incubation of the vessels with cocaine (3 μM) for at least 15 min to establish a neuronal 
uptake-blockade.  
 
Drugs and solutions 
The KRB-solution contained the following compounds (mmol/l): NaCl 118.5, KCl 4.7, 
MgSO4·7H2O 1.2, NaHCO3 25.0, CaCl2 2.5, KH2PO4 1.2 and glucose 5.5. K-KRB contained 
an equimolar concentration of KCl instead of NaCl. We diluted noradrenaline, vasopressin, 
angiotensin II and L-NAME (Sigma Chemical Co., St Louis, MO, USA) with distilled water 
to the final concentration. 
 
Morphometry 
After completion of the contractile experiments, the arteries were fixed at the optimal 
lumen diameter for 30 min in 4% phosphate-buffered (pH 7.4) paraformaldehyde and 
embedded in paraffin. Cross-sections (4 µm) were stained with Lawson’s solution (Boom 
B.V., Meppel, The Netherlands) to visualize the internal and external elastic laminae. By 
using a Zeis Axioscope (Zeiss, Germany) and a standard CCD camera (Stemmer, Germany), 
images of the cross-sections were generated. We calculated the media cross-sectional area 
(CSA) by subtracting the area enclosed by the internal elastic lamina from that enclosed by 
the media-adventitial border. Assuming a circular cross-sectional profile, we calculated the 
lumen radius from the internal circumference as well as the average media thickness (Mt) and 
the wall-to-lumen ratio (W/L; x100). 
 
Statistics 
Contractile responses are expressed as increases in wall tension (force/2x segment 
length). Concentration-response curves were analyzed by calculating sensitivity (pD2 = -log 
EC50) and maximal responses (Emax) by curve fitting of the individual concentration-response 
curves. In the tables and figures we presented the data as means±SEM. We evaluated 
intergroup differences by analysis of variance (ANOVA). A p<0.05 was considered to 
indicate a significant difference. 
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RESULTS 
 
Vasoconstrictor responses mediated by sympathetic nerves 
At basal tone EFS (90 V; 0.5-32 Hz) induced a frequency-dependent vasoconstriction. 
These responses were diminished by over 95% in the presence of 1 µM prazosin or 1 µM 
tetrodotoxin indicating that they are mediated by peri-arterial sympathetic nerves. The 
maximal response of mesenteric arteries to EFS was 40% smaller in pregnant than in 
nonpregnant rats (figure 1a, table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
Fig. 1. Vasoconstrictor responses of mesenteric arteries in nonpregnant (●, n=12) and pregnant rats         
(○, n=12) to (a) EFS, (b) noradrenaline (NA), (c) angiotensin II (ATII) and (d) vasopressin (AVP). 
*p<0.05 for maximal responses (Emax); #p<0.05 for sensitivity (pD2) 
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Table 1. Sensitivity (pD2) and maximal contractile response (Emax) presented as mean±SEM.  
 
      EFS      NA     ATII    AVP 
PD2 NP  5.67±0.21 8.95±0.06 8.83±0.08 
 P  4.49±0.52* 8.48±0.17* 8.70±0.12 
      
Emax NP 3.08±0.42 3.76±0.36 0.33±0.17 3.72±0.33 
(mN/m) P 1.70±0.46* 2.82±0.22* 0.17±0.13 3.28±0.37 
 
* indicates nonpregnant (NP) being significant different (p<0.05) from pregnant rat (P).  
NA: noradrenaline; ATII: angiotensin II; AVP: vasopressin. 
 
 
 
 
 
Vasoconstrictor responses to noradrenaline, angiotensin II and vasopressin 
The vasoconstrictor response to noradrenaline and angiotensin II of mesenteric arteries 
was smaller in pregnant than in nonpregnant rats (figure 1b and c). Analysis of the concentra-
tion-response curves also indicated that pregnancy was associated with a lower sensitivity to 
noradrenaline and angiotensin II, a lower maximal response to noradrenaline, and a trend to a 
lower maximal response to angiotensin II, relative to the nonpregnant state (table 1; figure 1). 
 
Effect of L-NAME on vasoconstrictor response 
Only in nonpregnant rats, L-NAME seemed to increase the vasoconstrictor response to 
EFS, but this effect did not reach statistical significance (data not shown). The effect of L-
NAME on the mesenteric artery responses to EFS, noradrenaline, angiotensin II and 
vasopressin was small and inconsistent in both groups of rats.  As a consequence, the 
observed difference in arterial response to EFS, noradrenaline and angiotensin II between 
both groups was not abolished by L-NAME. Specially, in the pregnant group responses to 
these stimuli were almost identical after incubation with L-NAME (figure 2).  
Inhibition of the neuronal uptake by cocaine increased the magnitude of the responses to 
EFS similarly in both groups. However, the responses of mesenteric arteries were still smaller 
in pregnant rats than in nonpregnant rats (data not shown). 
 
Morphometry 
Morphometric parameters of mesenteric arteries from nonpregnant and 10-day pregnant 
rats were comparable (table 2).   
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Table 2. Morphometric parameters in nonpregnant (NP) and pregnant rats (P) 
       NP         P 
CSA (μm2)  1217±198  1286±304 
radius (μm)    151±10    147±8 
Mt (μm) 12.14±1.16 12.93±2.14 
W/L (x100)   7.99±0.14   8.65±1.23 
 
Media cross-sectional area (CSA), radius, media thickness (Mt) and wall-to-lumen ratio (W/L), all expressed 
as mean±SEM for NP and P. 
 
 
 
DISCUSSION 
 
The results of this study in mesenteric arteries indicate that pregnancy reduces the 
vasoconstrictor response to perivascular sympathetic nerve stimulation, to angiotensin II and 
to noradrenaline, but not to vasopressin. We made these observations at day 10 of rat 
pregnancy, when pregnancy-related hemodynamic changes are instituted and measurable [4].  
  
 
Fig.2. Vasoconstrictor responses of 
mesenteric arteries of pregnant rats to (a) 
EFS, (b) noradrenaline (NA), (c) angiotensin 
II (ATII) before - (○) and after incubation 
with  L-NAME (●). 
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Our observation on the effect of pregnancy on the vasoconstrictor response to 
sympathetic nerve stimulation confirms data reported by others [6,12-15]. However, the data 
on the effect of pregnancy on the vasoconstrictor response to noradrenaline are unsettled as 
some investigators reported a weaker response [12,16-18], whereas others reported 
inconsistent effects [6,19]. Almost all data reported on this topic, have been gathered in late 
pregnancy. Therefore, it is conceivable that inconsistent responses in late pregnancy are 
consequences of the increasing variability in many maternal functions with advancing 
pregnancy, caused by the progressively increasing metabolic and circulatory impact of the 
conceptus on the mother. 
We observed a reduced sensitivity to noradrenaline in 10-days pregnant rats. It is still unclear, 
whether this reflects involvement of a prejunctional factor in the mechanism of early-preg-
nancy vasodilatation. To the best of our knowledge, there is no experimental evidence for 
degeneration of perivascular sympathetic nerves [12], a lower perivascular noradrenaline 
content [20] or enhanced re-uptake and/or degeneration of endogenously released 
noradrenaline in non-uterine arteries during rat pregnancy. Blockage of neuronal uptake of 
endogenously-released noradrenalin by cocaine did not abolish the lower arterial response in 
pregnancy, thus rejecting the option of an enhanced uptake of the transmitter. It is possible 
that neurotransmitters other than noradrenaline are involved in the weaker vasoconstrictor 
response to EFS in pregnancy. In a recent study, we found that mesenteric arteries release 
calcitonin gene-related peptide from their sensory-motor nerves during stimulation with K+ 
and that pregnancy had altered this response [21]. This could indicate that the attenuated 
neurogenic vasoconstrictor response of mesenteric arteries in pregnancy results from enhanced 
effects of calcitonin gene-related peptide released by sensory-motor nerves during EFS. 
Pregnancy reduced the contractile response to angiotensin II and noradrenaline, but did 
not seem to affect that to vasopressin and K+ [21]. This may indicate that pregnancy 
selectively inhibits the signal transduction pathways initiated by angiotensin 1 and α1-
adrenergic receptor activation. In view of current knowledge about signal-transduction 
[22,23], depolarisation-induced calcium-influx through voltage-operated calcium channels 
and modulation of calcium-sensitivity by the RhoA/Rho-kinase pathway would not be 
affected, while response due to signalling through phospholipase C and protein kinase C 
would be selectively impaired.  Pregnancy may also indirectly reduce the vasoconstrictor 
response of the stimuli mentioned above, e.g. by the concomitant enhanced endometrial 
release of vasodilators. It is known that α2-adrenoreceptor stimulation triggers inducible-
nitric-oxide-dependent vasodilatation. Therefore, we also evaluated the effect of nitric oxide 
synthase inhibition by L-NAME on the pregnancy-related reduction in vasoconstrictor re-
sponse. Neither we, nor others [6,12,19,24] were able to demonstrate a consistent effect of L-
ROLE OF NO AND VASCULAR REMODELING IN PREGNANCY 
________________________________________________________________________ 
88 
 
NAME suggesting that the pregnancy-dependent decrease in vasoconstrictor response de-
velops independently of nitric oxide modulation [6,12,19,24]. 
In contrast to others [6,12,25], we did not find a lower pressor response to vasopressin in 
pregnancy. Since we did find a trend to a decreased pressor response to vasopressin in mid-
pregnancy, it is possible that the blunted pressor response described by others is limited to late 
pregnancy.  
Vascular remodeling, which consists of an increase in distensibility and a decrease of the 
arterial wall thickness, could have contributed to blunted pressor responses in mid-pregnancy. 
Previously, we reported a rise in aortic compliance and distensibility [26] in mid-pregnant rat. 
Our data on vascular morphology in this study indicate absence of remodeling of the 
mesenteric artery by 10-days pregnancy. It follows that vascular remodeling does not 
contribute to the observed blunted vasoconstrictor response by 10-days pregnancy.  
In summary, early pregnancy blunts some but not all vasoconstrictor responses in 
isolated mesenteric arteries of the rat. Neither modulation by endothelium-derived nitric oxide 
nor vascular wall remodeling can explain this effect. Therefore, it is likely that the reduced 
vasoconstrictor response in pregnancy is a selective effect of some yet unknown factor on the 
signal-transduction pathway in vascular smooth muscle cells. 
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In this thesis, we have studied various mechanisms possibly involved in the onset of 
early-pregnancy vasodilatation in the Wistar rat. Systemic vasodilatation in human and rat 
pregnancy are comparable [1] and initiate marked cardiovascular and renal changes resulting 
in the institution of a high-flow and low-resistance circulation. Hypertensive complications of 
human pregnancy are preceded by the defective development of these adaptive changes [2,3]. 
Therefore, unraveling the mechanisms leading to this vasorelaxation is expected to improve 
the insight in the etiology of hypertensive disorders of pregnancy. Today, management of 
these disorders is limited to symptomatic treatment and/or premature termination of 
pregnancy. However, better insight in the mechanisms of early vasodilatation is likely to 
accelerate the development of treatment modalities that may enable us to prevent, or at least 
delay the onset of these disorders.  
Chapter 2 presents our data on hemodynamics in chronically instrumented pseudo-
pregnant rats with and without a uterus. In both groups, cardiac output increases and total 
peripheral resistance decreases from day 4 postmating compared to baseline values. The 
observed changes resemble those in normal pregnancy and indicate that neither trophoblast 
nor uterus is needed for these changes to develop. It emphasizes the central role of the ovary 
(corpus luteum) and its hormones and not the trophoblast or uterus in triggering these 
changes.  
Chapter 3 describes our results on reactivity to CGRP of arteries from pregnant and 
nonpregnant rats mounted in myographs. In mesenteric arteries of pregnant rat, CGRP elicits 
a significantly stronger vasodilatation. We also demonstrated that administration of K+ 
stimulates the release of endogenous CGRP from the arterial sensory-motor nerves. Both, this 
release and the CGRP content from arteries did not differ between the pregnant and non-
pregnant group. These data provide evidence for a higher arterial sensitivity to CGRP in early 
pregnancy without a concomitant higher availability of CGRP. 
Chapter 4 elaborates on our observations related to the mechanism responsible for the 
higher vascular response to CGRP in pregnancy. We excluded the possibility of an MMP-2-
dependent reduction in the CGRP inactivation as an explanation for the higher CGRP activity 
in pregnancy. Density of CGRP binding sites in mesenteric arteries did not differ between 
pregnant and nonpregnant rats. The similar arterial response in pregnant and nonpregnant rats 
to direct stimulation of adenylyl cyclase supports the view that enhanced coupling of CGRP 
receptors to adenylyl cyclase rather than an altered downstream signal-transduction pathway 
is responsible for the higher arterial response to CGRP in pregnancy. 
GENERAL DISCUSSION AND SUMMARY 
________________________________________________________________________ 
94 
 
Chapter 5 presents our data on the vasodilator activity of adrenomedullin (ADM) which 
belongs to the same superfamily of peptides as CGRP. Vasoactive responses to this peptide of 
mesenteric and uterine arteries preconstricted by EFS were higher in the pregnant group. As 
this response did not occur in arteries preconstricted by noradrenalin, the ADM effect appears 
to be a prejunctional effect on perivascular sympathetic nerves. On the other hand, mesenteric 
arteries preconstricted by K+ only responded differently to ADM in pregnancy relative to 
nonpregnancy after desensitization of the sensory-motor nerves by capsaicin. This provides 
evidence for a postjunctional mechanism, possibly orchestrated by a change in the function of 
the common calcitonin-receptor-like receptor. 
Chapter 6 outlines our results regarding blunted vascular responses of mesenteric 
arteries in pregnancy to sympathetic nerve stimulation by EFS, noradrenaline and angiotensin 
II. These blunted responses persisted in conditions of inhibited nitric oxide synthase. 
Mesenteric arteries of 10-day pregnant and nonpregnant rats were morphometrically similar. 
The data from this study provide evidence for the concept that neither NO nor vascular 
remodeling contribute to the early-pregnancy vasorelaxation. 
Our studies on the mechanism of vasodilatation in early pregnancy provide experimental 
evidence for the view that the predominance of vasodilatation in pregnancy results from a 
change in the response to vasodilators as well as to vasoconstrictors, with these changes 
taking place both at the pre- and post-junctional level.  
 
SEX STEROIDS: THE HORMONAL ENVIRONMENT IN PREGNANCY IS A PREREQUISITE 
FOR EARLY PREGNANCY VASORELAXATION 
Pregnancy is a condition characterized by elevated estrogen and progesterone levels of 
both ovarian and placental origin. Sex steroids remain elevated throughout pregnancy and 
play a crucial role in its normal development. Removal of the corpus luteum ‒ the ovarian 
source of sex steroid production ‒ before the so-called luteo-placental shift results in a 
miscarriage. Progesterone and 17β-estradiol have a wide range of effects on target cells in 
reproductive tissues mediated by genomic and nongenomic pathways [4,5]. They also play a 
role in the vascular function through their specific receptors in the endothelium and vascular 
smooth muscle cells [6-8]. Progesterone and 17β-estradiol have vasodilator properties [9-13], 
which raises the question, whether pregnancy-like hemodynamic changes can be mimicked by 
creating an identical hormonal environment in nonpregnant animals. To our knowledge such 
an experimental setup in animal models has never been reported. As hormonal changes in 
pseudopregnant rats resemble closely those in early normal pregnant rats [14-16], the 
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pseudopregnant rat represents an elegant experimental model to study the independent 
contribution of luteal hormones on the early-pregnancy cardiovascular adaptation. Chapter 2 
presents our data on hemodynamic changes in hysterectomized pseudopregnant rats. The 
observed changes are almost identical to the ones in intact pseudopregnant - and normal 
pregnant rats. Progesterone receptor blockade also eliminated the systemic vasodilatation in 
pseudopregnant rats (unpublished data). Although, we did not measure the hormonal levels in 
that study, this observation provides indirect support for the concept that luteal hormones play 
a crucial role in triggering the initial hemodynamic adaptation. From these data we concluded 
that luteal hormones play a critical role in creating the hormonal environment necessary for 
early-pregnancy vasodilatation. 
 
PERIVASCULAR NERVES: CHANGES AT THE PREJUNCTIONAL LEVEL IN PREGNANCY 
In chapter 6 we presented our data supporting a lower contractile responsiveness of 
mesenteric arteries during pregnancy to both noradrenaline and electrical field stimulation of 
its sympathetic nerves. The experimental design of this study, though, did not enable us to 
determine, whether the latter effects were a consequence of pre- or postjunctional sympathetic 
changes. Alterations in sympathetic nerve density on the one hand, and release, uptake or 
degradation of transmitter content, on the other hand, may be involved. Mesenteric arteries 
display a higher neuronal uptake of cathecholamines in late-pregnant than in nonpregnant rats 
[17]. However, using the same experimental setup with blockade of noradrenaline reuptake, 
we were unable to reproduce this effect in early pregnancy. Although, the uterus is known for 
its sympathetic nerve degeneration during pregnancy [18-20], there is no experimental 
evidence for a similar effect in the arterial wall in early pregnancy [21]. Our data presented in 
chapter 5 provide evidence for adrenomedullin inducing a stronger vasodilator response in 
arteries of pregnant than in arteries of nonpregnant rats during neurogenic constriction, but 
not after being preconstricted by noradrenaline. These observations support the concept that 
adrenomedullin inhibits the effect of sympathetic nerves at the prejunctional level. 
Adrenomedullin is a vasodilator peptide with both endothelium-dependent and independent 
vasodilator activity. One of the properties of adrenomedullin is the inhibition of noradrenaline 
release by adrenergic nerves [22-24]. Therefore, adrenomedullin may be indirectly involved 
in the early-pregnancy vasodilatation by its inhibiting effect on sympathetic nervous function. 
CGRP is released from sensory-motor nerves distributed throughout the cardiovascular 
system. Although circulating levels of CGRP [25] and vascular sensitivity to CGRP increase 
in pregnancy (chapter 3), we did not find a concomitant rise in perivascular sensory-motor 
nerve density or CGRP content (chapter 3). The latter observation indicates that a 
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prejunctional effect is highly unlikely in the pregnancy-related increased CGRP sensitivity 
and thus, opposes a role of sensory-motor nerves at a prejunctional level and of the raised 
circulating levels of CGRP in the early-pregnancy vasodilatation. There is experimental 
evidence for sensory-motor nerves and sympathetic nerves to share a common topography 
and to act as functional antagonists through their transmitters CGRP and Neuropeptide Y 
[26]. Like adrenomedullin, CGRP inhibits the release of noradrenaline from sympathetic 
nerves [27,28]. Furthermore, in chapter 5 we described a clear rise in adrenomedullin activity 
in the absence of CGRP after desensitization of the sensory-motor nerves. As mentioned 
earlier, adrenomedullin modulates sympathetic innervation. We speculate that altered 
crosstalk between these neurovascular systems is involved in the early-pregnancy 
vasodilatation. 
 
RECEPTORS: CHANGES IN PREGNANCY 
We demonstrated that both CGRP (chapter 3) and adrenomedullin (chapter 5) elicit 
increased vasodilator responses in mesenteric arteries of pregnant rat. Our data suggest that at 
least part of this effect is due to postjunctional changes. We also noticed that pregnancy did 
not change the vasodilator response of the post-receptor transduction pathway of CGRP, 
which implies that the higher sensitivity to vasodilators in pregnancy results from a change at 
the receptor level. CGRP and adrenomedullin use calcitonin receptor-like receptor (CRLR), 
which can both function as a CGRP - and as an ADM receptor, depending on the coupling to 
so-called receptor-activity-modifying proteins (RAMP’s). CRLR may either bind to RAMP1 
to form the CGRP-A receptor, or to RAMP2 or RAMP3 to form the ADM receptor [29,30]. In 
mesenteric arteries of pregnant rats, mRNA levels of RAMP1 increase gradually from early 
pregnancy onward [31] as opposed to CRLR, which does not change until day 18, to increase 
sharply afterwards [31]. These observations are in line with our data of unchanged CGRP 
arterial binding sites by day 10 of pregnancy relative to the pre-pregnant condition. The 
regulation of CRLR-RAMP coupling is still poorly understood. Studies in endothelial cell 
lines indicate that interaction between RAMP’s can lead to competition between the different 
RAMP types [32]. Whether such dynamic interaction plays a role in the increased vasodilator 
responsiveness to CGRP in pregnancy is unsettled. In rat uterus ADM receptors are up-
regulated during pregnancy [33]. However, it is unknown, whether such effect can be found 
in arteries. In chapter 5, we described the pregnancy-dependent stronger relaxation of 
mesenteric arteries in response to adrenomedullin in the absence of endogenously released 
CGRP. This finding could indicate that changes in receptor coupling modulated by changes in 
coupling to RAMPs are responsible for the increased relaxing responses to both 
adrenomedullin and CGRP in pregnancy. The role of the CGRP-receptor component (RCP) in 
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this context is still unclear. The RCP allows direct coupling of the CGRP receptor to the 
intracellular signalling pathway [34,35]. Recently, it was demonstrated that human pregnancy 
is associated with an increased myometrial mRNA expression of CGRP-RCP [36]. We 
speculate that early pregnancy is a state with increased receptor coupling modulated by 
changes in RCP and/or RAMP. Reproductive steroids, changes in the levels of CGRP and/or 
adrenomedullin, but also interaction between the RAMPs are potential mechanisms respons-
ible for these changes.    
In chapter 6, we describe reduced vasoconstrictor responsiveness to both electrical field 
stimulation and noradrenaline. There is no evidence for pregnancy-induced changes in vas-
cular α2 or β-adrenergic receptors [37]. Animal studies on this subject are scarce and provide 
conflicting results with both increased [38] or unchanged [39,40] levels of arterial α1-
adrenergic receptors. Therefore, experimental evidence supporting a change in the adrenergic 
receptors or their coupling to G-proteins being responsible for the early-pregnancy vascular 
relaxation is lacking. Meanwhile, a pregnancy-induced fall in the ratio of angiotensin-1      
(vasoconstriction) and angiotensin-2 receptors (vasodilatation) is thought to explain the lack 
of response to infused angiotensin II in the pregnant uterine artery [41]. As a matter of fact, in 
the renal cortex of pregnant rats this lower ratio is well documented. Finally, inhibition of 
angiotensin II by relaxin is also documented [42,43]. Together with the recently provided 
evidence for a relaxin ligand-receptor system in renal and mesenteric arteries of rats [44] this 
presents another potential candidate in the regulation of arterial function in pregnancy. 
 
The studies incorporated in this thesis did not identify a single factor responsible for the 
early-pregnancy vasodilatation. Instead, they support the concept of a complex pattern of 
changes in different vasoactive systems. These changes are summarized in a cartoon at the 
end of this chapter. Estrogen and progesterone seem to provide the endocrine environment 
essential for these vascular changes to evolve. The studies brought together in this thesis 
unravel some of the mechanisms responsible for these changes. However, many questions 
remain unanswered and further research is needed to fill in the question marks in the diagram. 
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Figure. A schematic diagram of potential (dotted lines) and established (black and blue – this thesis ‒ 
lines) effects of different vasoactive factors and their receptors on vasodilatation in pregnancy. Relaxin 
(RLX), ADM (adrenomedullin), CGRP (calcitonin gene-related peptide) ET-1 (endothelin 1), Ang II 
(angiotensin II), NA (noradrenalin), NO (nitric oxide). 
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In de vroege zwangerschap treden indrukwekkende veranderingen op in de 
bloedsomloop, nierfunctie en vochthuishouding bij de moeder. Hoewel de exacte betekenis 
van deze hemodynamische  aanpassingen niet bekend is  blijkt een gestoord verloop hiervan 
te leiden tot ernstige zwangerschapscomplicaties zoals intra-uteriene groeivertraging en pre-
eclampsie.  
De hemodynamische veranderingen worden vooraf gegaan door een voor de 
zwangerschap specifieke, systemische vaatverwijding. Inzicht in het mechanisme dat 
verantwoordelijk is voor deze vaatverwijding kan een belangrijke bijdrage leveren aan het 
onderzoek naar de oorzaak van de maternale hypertensieve complicaties tijdens de 
zwangerschap. Doel van dit proefschrift is de exploratie van mogelijke factoren die 
verantwoordelijk zouden kunnen zijn voor de systemische vaatverwijding in de vroege 
zwangerschap. Omdat de voor de zwangerschap specifieke hemodynamische aanpassingen in 
de mens en de rat sterk overeenkomen is de rat een geschikt proefdier voor dit onderzoek. 
Voor de studies beschreven in dit proefschrift werd zowel gebruik gemaakt van een in vivo 
model als van geïsoleerde arteriën van de rat.  
 
In hoofdstuk 1 wordt een literatuuroverzicht gegeven van mogelijk factoren die een rol 
zouden kunnen spelen bij het ontstaan van de systemische vaatverwijding in de vroege 
zwangerschap. Op basis van dit overzicht werden de volgende vragen geformuleerd: 
• Is het voor de zwangerschap karakteristieke hormonale milieu, wat in de vroege 
zwangerschap bepaald wordt door steroïden van luteale oorsprong, noodzakelijk 
voor de inductie van de systemische vaatverwijding? 
• Spelen de krachtige vaatverwijders CGRP en ADM onder invloed van deze 
steroïden een rol bij het ontstaan van de systemische vaatverwijding? 
• Is de verminderde contractiele respons van arteriën op verschillende vaatvernauwers, 
die gevonden wordt aan het einde van de zwangerschap, ook een factor in de vroege 
zwangerschap? En speelt NO of een veranderde morfometrie van de vaatwand een 
rol in dit proces?  
 
Hoofdstuk 2 beschrijft de hemodynamische aanpassingen in schijnzwangere ratten met 
en zonder uterus. In beide groepen wordt vanaf dag 4 van de schijnzwangerschap een toename 
gezien van het hartminuutvolume en een afname van de perifere vasculaire weerstand. Deze 
veranderingen zijn vergelijkbaar met de hemodynamische veranderingen in de gewone 
zwangere rat. Aangezien de hormonale veranderingen in de vroege zwangerschap en 
schijnzwangerschap van de rat vrijwel identiek zijn, is het aannemelijk dat zowel de 
trophoblast als de uterus niet nodig zijn voor het ontstaan van de systemische vaatverwijding 
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in de zwangerschap. Moederlijke hormonen afkomstig van de ovaria (corpus luteum) lijken 
daarentegen cruciaal voor deze hemodynamische aanpassingen. 
 
De studie beschreven in hoofdstuk 3 laat zien dat kleine arteriën afkomstig uit het 
mesenterium van zwangere ratten een sterkere vaatverwijding laten zien na toediening van 
CGRP dan arteriën van niet zwangere ratten. Tevens wordt aangetoond dat K+ de afgifte van 
CGRP uit sensore motor zenuwen in de vaatwand stimuleert. Zowel deze afgifte als het totale 
gehalte van CGRP in de arteriële vaatwand laat geen verschil zien tussen de zwangere en niet 
zwangere groep. Deze gegevens tonen aan dat bepaalde arteriën in de vroege zwangerschap 
gevoeliger zijn voor CGRP zonder dat er meer CGRP beschikbaar is. 
 
In hoofdstuk 4 wordt de studie beschreven waarin mogelijke mechanismen, die 
verantwoordelijk zouden kunnen zijn voor de toegenomen gevoeligheid voor CGRP in de 
zwangerschap, verder worden onderzocht. Er wordt aangetoond dat er geen verminderde 
afbraak van CGRP door MMP-2 in de zwangerschap plaats vindt. Tevens blijkt het aantal 
CGRP receptoren in mesenteriale arteriën niet te verschillen tussen de zwangere en niet 
zwangere groep. Directe stimulatie van adenylyl cyclase door forskoline geeft een 
vergelijkbare arteriële vaatverwijding in beide groepen. Deze bevinding maakt het 
waarschijnlijk dat de grotere gevoeligheid voor CGRP in de zwangerschap verklaard kan 
worden door veranderingen ter hoogte van de CGRP-receptor en niet door veranderingen in 
de signaal transductie voorbij dit niveau in de gladde spiercellen van de vaatwand. 
 
In hoofdstuk 5 worden de resultaten beschreven van de vaatverwijdende activiteit van 
ADM in de zwangerschap. Kleine arteriën werden in de myograaf gestimuleerd door 
elektrische prikkels waardoor de sympatische zenuwen worden geactiveerd. De afname van 
de vaatvernauwing ten gevolge van deze prikkels na toediening van ADM  was groter in de 
zwangere groep. Dit verschil werd niet gezien als de vaatvernauwing werd geïnduceerd door 
rechtstreekse toediening van noradrenaline. Derhalve lijkt dit effect van ADM het resultaat te 
zijn van een effect op de sympatische zenuwen. Als de arteriën tot vernauwing worden 
gebracht door K+ wordt ook een toename van de activiteit van ADM gezien in de zwangere 
groep. Deze toename treedt echter alleen op nadat de sensore motor zenuwen zijn kapot 
gemaakt door capsaicine. Dit toont aan dat ADM ook op het niveau van de gladde spiercel 
een toename van activiteit laat zien, mogelijk door veranderingen in de functie van de 
gemeenschappelijke receptor van ADM en CGRP. 
 
In hoofdstuk 6 wordt de afgenomen vasculaire activiteit van mesenteriale arteriën van 
zwangere ratten na stimulatie van de sympatische zenuwen en na toediening van 
CHAPTER 8 
________________________________________________________________________ 
 
107 
 
noradrenaline en angiotensine II. Deze afgenomen activiteit ten gevolge van de zwangerschap 
bleef ook bestaan na onderdrukking van NO synthase. Verder bleek de morfometrie van de 
kleine arteriën van het mesenterium niet te verschillen tussen zwangere en niet zwangere 
ratten. Deze studie toont aan dat de afgenomen vasculaire activiteit van verschillende 
vaatvernauwers in de zwangerschap niet het gevolg is van veranderde werking van NO of 
door morfometrische veranderingen van de arteriële vaatwand. 
 
Concluderend is er niet slechts één factor aan te wijzen die verantwoordelijk is voor de 
systemische vaatverwijding in de vroege zwangerschap. Veel meer is er sprake van een 
complex samenspel van verschillende, soms elkaar tegenwerkende, en op verschillende 
niveaus in de vaatwand aangrijpende factoren die bijdragen aan deze hemodynamische 
aanpassing in de zwangerschap. Steroïden afkomstig van de ovaria zijn in ieder geval cruciaal 
en lijken het hele proces van vaatverwijding te dirigeren. Enerzijds is de gevoeligheid van 
sommige arteriën  voor de krachtige vaat verwijder CGRP toegenomen, anderzijds is er 
sprake van een verminderde contractiele respons op sympatische prikkeling. Dit laatste 
mogelijk onder invloed van ADM. De verminderde contractiele respons op andere 
vaatvernauwers lijkt niet te worden bepaald door het endotheel of structurele morfometrische 
veranderingen van de vaatwand. Verder onderzoek is noodzakelijk  om de exacte rol en de 
onderlinge verbanden tussen de verschillende factoren die een rol spelen bij de systemische 
vaatverwijding in de vroege zwangerschap te ontrafelen. 
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Dankwoord 
 
 
 
Het heeft even geduurd maar uiteindelijk is het wetenschappelijk onderzoek waarmee ik 
gestart ben tijdens mijn tijd in Maastricht, afgerond in de vorm van dit proefschrift. Dit was 
waarschijnlijk nooit gelukt zonder de steun en het geduld van velen. Hoewel ik inmiddels in 
een nieuwe fase van mijn leven zit met nieuwe wetenschappelijke uitdagingen, zijn de 
herinneringen aan de samenwerking met hen die betrokken zijn bij de totstandkoming van dit 
proefschrift nog altijd goed. Ook tijdens mijn huidige werkzaamheden in Zwolle heb ik veel 
steun ondervonden bij het afronden van dit werk. In het bijzonder wil ik de volgende mensen 
bedanken: 
 
Dr. L.L.H. Peeters, beste Louis, de laatste jaren heb ik niet alleen veel bewondering 
gekregen voor je creativiteit en kennis van de zwangere vrouw, maar ook voor je geduld en je 
immer positieve instelling. Als inspirator van vele onderzoekers en begeleider van een groot 
aantal promovendi durf ik te stellen dat Maastricht in vele opzichten te klein is voor jou. 
 
Prof. dr. J.G.R. De Mey, beste Jo, als “vreemde gynaecologische eend in de 
farmacologische bijt” heb ik me altijd een welkome gast gevoeld in jouw laboratorium. Dat 
de samenwerking tussen twee heel verschillende disciplines tot mooie resultaten kan leiden 
bewijst dit proefschrift. Jouw grote kennis van de farmacologie en vermogen ingewikkelde 
zaken op een eenvoudige wijze aan een buitenstaander duidelijk te maken hebben daar in 
belangrijke mate toe bijgedragen. 
 
Prof. dr. J. de Haan, beste Jelte, voor goed wetenschappelijk onderzoek is een goed 
wetenschappelijk klimaat nodig. Eerst als opleider, later als directeur van GROW was je als 
geen ander in staat de juiste voorwaarden hiervoor te creëren. Het doet me groot genoegen dit 
werk onder jouw promotorschap te mogen afronden. 
 
De leden van de beoordelingscommissie: Prof. dr. G.G.M. Essed (voorzitter), Prof. dr. J. 
Glatz, Prof. dr. P.W. de Leeuw en Prof. Dr. H.A.J. Struijker Boudier wil ik bedanken voor de 
moeite die zij hebben genomen om dit proefschrift te beoordelen. 
 
Marijke Sanders en Brigitte Slangen, beste Marijke en Brigitte, jullie beiden hebben op 
geheel eigen wijze geholpen bij mijn eerste stappen op het gebied van het dierexperimenteel 
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onderzoek. De verschillende technieken die nodig waren bij de in vivo experimenten en de 
myograaf studies had ik mij zonder jullie hulp nooit eigen kunnen maken. 
 
Alle medewerkers van de afdeling farmacologie en toxicologie, maar in het bijzonder 
Gregorio Fazzi en Ger Janssen, wil ik bedanken voor de hulp bij de verschillende 
experimenten in het laboratorium. Om eens een tijd buiten het ziekenhuis in zo’n geheel 
andere omgeving te mogen werken, heb ik als bijzonder inspirerend ervaren. Hartelijk dank 
daarvoor.  
 
Mijn lotgenoten binnen het PERIM, Robert Aardenburg, Audrey Coumans, Dorette 
Courtar, Olivier van der Heijden en Marc Spaanderman wil ik bedanken voor de mooie tijd in 
Maastricht en vooral ook tijdens de gezamenlijk bezochte congressen. 
 
Thea Schenk, beste Thea, dank voor je hulp bij de laatste loodjes, de snelheid waarmee 
jij op zeer secure wijze dit proefschrift hebt opgemaakt vind ik nog steeds verbazingwekkend. 
Leny van Ingen, beste Leny, al zoveel jaren verbonden aan onze maatschap gynaecologie. 
Vanzelfsprekend heb je ook aan dit werk, en dan vooral bij de distributie je steentje 
bijgedragen. Bedankt. 
 
Mijn paranimfen Ben Cohlen en Jan den Boon, beste Ben, als fietsmaatje richting werk 
en schoolplein brengen we ongemerkt heel wat tijd samen door. De vele voor- en 
nabeschouwingen van werk en andere dagelijkse beslommeringen en de gedeelde passie voor 
chips en Cola vormen een goede basis om jou als paranimf aan mijn zijde te hebben.  
Beste Jan, met ons gezamenlijk aandachtsgebied, hebben we de laatste jaren heel wat uur 
samen aan de operatietafel, tijdens besprekingen en op congres doorgebracht. Ik merk dat ik 
nog steeds veel van je kan leren. De laatste jaren wordt duidelijk dat we met de 
urogynaecologie iets moois aan het opbouwen zijn in Zwolle. Dat jij mijn paranimf bent is 
hiervan het logische gevolg, en ongetwijfeld een voorbode van wat er op wetenschappelijk 
gebied gaat volgen. 
 
Maatschap Zwolse Vrouwenartsen, beste Bas, Ben, Gerald, Hans, Harm, Henk, Jan, 
Jeroen, Jim, Joke, Mieke en Walter, door de moed waarmee we de laatste jaren veranderingen 
hebben doorgevoerd zijn we uitgegroeid tot een geweldige club. Een maatschap die iedere 
dag weer grensverleggend durft bezig te zijn, en dat bevalt prima. Hartelijk dank voor jullie 
steun en belangstelling in de afgelopen jaren. 
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Lieve vader en moeder, eindelijk is het dan klaar. De vaardigheden die je nodig hebt om 
een proefschrift te schrijven worden natuurlijk grotendeels op jonge leeftijd door je ouders 
meegegeven. Dus ook jullie mogen trots zijn op dit werk. 
 
Lieve Marieke, het is natuurlijk onzinnig om op deze plaats iets op te schrijven wat al 
vaak is uitgesproken. Toch doe ik het nog een keer: je weet dat je samen met de kinderen de 
allerbelangrijkste in mijn leven bent en dat ik dankbaar ben voor alles wat we samen hebben.  
 
Tenslotte, lieve, lieve Roos en Thijs, iedere dag verwonder ik me over jullie creativiteit, 
fantasie en scherpzinnigheid. Daarom zijn jullie echt de allerleukste mensen die ik ken en leer 
ik elke dag heel veel van jullie. Ik beloof jullie nog veel meer leuke dingen samen te gaan 
doen en nog heel veel samen te genieten. 
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Curriculum vitae 
 
Hugo van Eijndhoven werd op 30 januari 1967 geboren te Delft. Na het doorlopen van 
het atheneum op het Rhedens Lyceum in Velp, begon hij in 1985 met de studie geneeskunde 
aan de Rijksuniversiteit Groningen. Na afronding hiervan volgde tussen 1993 en 1996 
assistentschappen gynaecologie in het Weezenlanden ziekenhuis in Zwolle en het Canisius 
ziekenhuis in Nijmegen. In 1996 werd gestart met de opleiding tot gynaecoloog in het 
Academisch Ziekenhuis Maastricht (opleiders prof. dr. J. de Haan en prof. dr. J.L.H. Evers). 
De opleiding werd afgerond in het Maxima Medisch Centrum Veldhoven (opleiders prof. dr. 
H.A. Bröllman en prof. dr. G. Oei). De studies beschreven in dit proefschrift werden 
grotendeels verricht tijdens zijn opleiding op het laboratorium van de afdeling farmacologie 
van de Rijksuniversiteit Limburg.  
Vanaf juli 2003 is hij werkzaam als gynaecoloog in de Isala klinieken Zwolle, waar hij 
zich geheel niet in overeenstemming met dit proefschrift vooral bezig houdt met de 
bekkenbodem gynaecologie. 
 
